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The mammalian retina provides an excellent opportunity to study gliaeneuron interactions and the
interactions of glia with blood vessels. Three main types of glial cells are found in the mammalian retina
that serve to maintain retinal homeostasis: astrocytes, Müller cells and resident microglia. Müller cells,
astrocytes and microglia not only provide structural support but they are also involved in metabolism,
the phagocytosis of neuronal debris, the release of certain transmitters and trophic factors and Kþ up-
take. Astrocytes are mostly located in the nerve ﬁbre layer and they accompany the blood vessels in the
inner nuclear layer. Indeed, like Müller cells, astrocytic processes cover the blood vessels forming the
retinal blood barrier and they fulﬁl a signiﬁcant role in ion homeostasis. Among other activities, microglia
can be stimulated to fulﬁl a macrophage function, as well as to interact with other glial cells and neurons
by secreting growth factors. This review summarizes the main functional relationships between retinal; Ach, acetylcholine; AGA, amadori-glycated albumin; AGE, advanced glycation end-products; AhR, aryl hydrocarbon
acular degeneration; AP-1, activating protein-1; APC, antigen-presenting cells; Apo, apolipoprotein; AQP, aquaporin;
1; Atoh7, atonal homolog 7; ATP, adenosine triphosphate; BBB, bloodebrain barrier; Bcl-2, B-cell lymphoma 2; BDNF,
ast growth factor; BMP, bone morphogenetic protein; BV, blood vessel; CaMKII, Ca2þ/calmodulin-dependent protein
hemotactic Protein-1; CCR2, CeC chemokine receptor type 2; CD45, cluster of differentiation 45; Cdc14A, cell division
roid; ChAT, choline acetyltransferase; CHX10, Ceh-10 homeodomain-containing homolog; CNS, central nervous system;
ovascularisation; CRALBP, cellular retinaldehyde-binding protein C; CREB, cAMP response element-binding protein;
ndroitin sulphate proteoglycans; CTGF, connective tissue growth factor; CX3CL1, chemokine (C-X3-C Motif) Ligand 1;
idino-2-phenylindole; DAPT, g-Secretase inhibitor; DHA, docosahexaenoic acid; DKK3, Dickkopf-related protein 3; DR,
nsporter; ECM, extracellular matrix; ED-1, monoclonal antibody against glycoprotein CD68; EGF, epidermal growth
SMV, embryonic stem cells microvesicles; FG, ﬂuorogold; FGF, ﬁbroblast growth factor; FKN, fraktalkine; G6P, Glucose-
owth Arrest And DNA-Damage-Inducible Beta; GCL, ganglion cell layer; GDNF, glia-derived neurotrophic factor; GFAP,
otein; GK, Goto Kakizaki; GLAST, glutamate-aspartate transporter; GLT1, glial Glutamate Transporter 1; Gpc, glypican;
stem cells; HSPG, heparin sulphate proteoglycan; IBA1, ionized calcium-binding adapter molecule 1; IF, intermediate
or; IL, interleukin; ILM, inner limiting membrane; INL, inner nuclear layer; IOP, intraocular pressure; IP3R2, IP3 receptor
al kinase; Kir, inwardly rectifying potassium channels; LCA, Leber congenital amaurosis; LDL, low-density lipoproteins;
ory factor; MAPK, mitogen-activated protein kinases; Mash1, mammalian achaete-scute homolog-1; MCP1, monocyte
al growth factor-like domains protein 10; Mertk, tyrosine-protein kinase Mer; MHC, major histocompatibility complex;
target of rapamycin; NAD, nicotine adenine dinucleotide; NADPH, nicotinamide adenine dinucleotide phosphate; NF,
r factor kappa-light-chain-enhancer of activated B cells; NGF, nerve growth factor; NMDA, N-Methyl-D-aspartate; NO,
-[(3-phenylpropyl)amino]benzoic acid; NV, neovascularisation; OIR, oxygen-induced retinopathy; OLM, outer limiting
r; OPC, oligodendrocyte precursor cells; OPL, outer plexiform layer; OPN, osteopontin; OS, outer segment layer; P2Y,
imary closed-angle glaucoma; PCG, primary congenital glaucoma; PE, pigment epithelium; PEDF, pigment epithelium-
phate 3-kinase; PKB, protein kinase B; PLC, phospholipase C; POAG, primary open angle glaucoma; PSD95, postsynaptic
P, red ﬂuorescent protein; RGC, retinal ganglion cells; RGCL, retinal ganglion cells layer; RNA, ribonucleic acid; ROS,
PE, retinal pigment epithelium; RT-PCR, reverse transcription polymerase chain reaction; RVD, regulatory Volume
on ionization-time of ﬂight; SNAP25, synaptosomal-associated protein 25; SP-A, surfactant protein A; Spbc25, spindle
activators of transcription transient; STZ, streptozotozin; TAK1, transforming growth factor b-activated kinase 1; TCA,
th factor beta; Thy-1, thymocyte antigen 1; TN-C, tenascin C; TNF, tumour necrosis factor; TRK&Bgr, tropomyosin re-
ator; VEGF, vascular endothelial growth factor; Vim, vimentin; WNT, Wingless-Type MMTV integration site family.
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Extracellular matrixglial cells and neurons, presenting a general picture of the retina recently modiﬁed based on experi-
mental observations. The preferential involvement of the distinct glia cells in terms of the activity in the
retina is discussed, for example, while Müller cells may serve as progenitors of retinal neurons, astrocytes
and microglia are responsible for synaptic pruning. Since different types of glia participate together in
certain activities in the retina, it is imperative to explore the order of redundancy and to explore the
heterogeneity among these cells. Recent studies revealed the association of glia cell heterogeneity with
speciﬁc functions. Finally, the neuroprotective effects of glia on photoreceptors and ganglion cells under
normal and adverse conditions will also be explored.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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The concept of neuroglia was ﬁrst proposed by Rudolf Virchow
in 1858, in reference to the cellular elements that make up the
connective tissue of the brain “nervekitt”. The Müller cell was
described as a radial ﬁbre in the retina by Heinrich Müller in 1851,
later becoming known as Müller glial cells. In 1893, the term
astrocyte ﬁrst appeared, used by Michael von Lenhossek in refer-
ence to the stellate morphology (from the Greek for star, astro, and
cell, cyte) of the cells that Camillo Golgi had previously seen in the
nervous system, describing them as the “glue” of the brain. These
cells were soon subdivided into ﬁbrous and protoplasmic astro-
cytes by Kolliker and Andriezen, yet their true diversity was not
fully appreciated until Ramon y Cajal's drawings revealed their
extraordinary pleomorphism. Based on his histological studies,
several roles for this diverse class of cells were postulated,
including a role in the maintenance of brain architecture, homeo-
stasis and nutrition. In 1919, oligodendrocytes (from the Greek for
few, oligo, branches, dendro, and cell cyte) and microglia were
recognized as separated cell types and categorised as neuroglia by
Pio del Rio-Hortega, one of the ﬁrst scientists to propose that
microglia are of mesodermal origin, and that they can migrate and
act as phagocytes (Kettenmann and Verkhratsky, 2008).
The vertebrate retina contains four types of glia, each of which
exhibits distinct morphological, developmental and antigenic
characteristics. Müller cells are the most predominant glial
element, followed by astrocytes and microglia. The fourth glial cell
type, the oligodendrocyte, is seen only occasionally in the retina,
associated with myelinated ganglion cell axons in a few species like
the rabbit. In this review, we will focus on general aspects of the
mammalian retina and thus, wewill notmention oligodendrocytes,
even though their activity and interactions with other astrocytes in
the optic nerve, and with retinal ganglion cell (RGC) axons, might
affect retinal function in some species (Fig. 1).
Despite studying the glia for more than a century the full inﬂu-
ence of glial cells on neuronal centres is still not fully clear. While
Cajal and others postulated several roles for glial cells (including
maintaining brain architecture, homoeostasis, nutrition and regu-
lating neuronal communication), we now know that glia are involved
in many other roles within the nervous system, for example inﬂu-
encing synaptic connectivity by controlling the genesis and mainte-
nance of synapses, and bymodifying synaptic strength and plasticity.
Although Müller, astrocytes and microglial cells each have a different
developmental origin, they share many functions within the retina.
Some of these activities are performed simultaneously, while others
are carried out by one or other of the glial cell types. More recently
glial cells have been established as a source of progenitors in the
brain, as not only can radial glia act as pluripotent neural precursors
but also, some astrocytes can re-enter the cell cycle and produce all
types of brain cells, from neurons to macroglial cells.
It is known that glial cells have intrinsic signalling systems that
can spread in the form of Ca2þ waves and that are correlated with
glutamate release. Among other functions, this signalling plays an
important role in immunity, angiogenesis and neuroprotection.
However, while neuroglia responds to injury as part of the defenceto restore homeostasis, when they malfunction, these cells become
what can be considered a primary pathogenic element. Little is
known about the regulation of gliaeglia and gliaeneuronal in-
teractions within the retina. However, since the retina is a well
structured organ within the Central Nervous System (CNS), studies
of the different roles of glial cells in health and disease have allowed
researchers to understand some of their interactions with neurons.
The interactions between glia and neurons contribute to retinal
homeostasis, and while some such interactions have been deﬁned,
we are still far from fully understanding how homeostasis is
maintained in the retina. Thus, in this review we will establish
some of the common features of glial cells in the retina and wewill
describe their possible interactions with neurons.2. Origin and morphology of the retinal glial cells
2.1. Müller cells
2.1.1. Origin and morphology of Müller cells
The Müller cell is the predominant glial element in the retina,
representing 90% of the retinal glia. These are radially oriented cells
that traverse the retina from its inner (vitreal) border to the distal
end of the outer nuclear layer (ONL: Fig. 2). Although Müller cells
share a lineage with retinal neurons, their time of birth appears to
be different. Recent studies found the surprising origin of Müller
cells in the neural crest cell (Liu et al., 2014a). Birth dating of retinal
neurons and Müller cells was determined by 3H-thymidine-label-
ling (Sidman, 1961) and all retinal cell types are generated in an
orderly fashion, the sequence of which is largely conserved among
vertebrates (Vecino and Acera, 2015). Accordingly, ganglion cells
are the ﬁrst cells to be born, followed closely by horizontal cells,
cones and displaced amacrine cells. At later stages, amacrine cells,
bipolar cells, rod cells and Müller cells are generated, and indeed,
the general consensus is that Müller cells are the last cells to
become post-mitotic (Cepko, 1993).
The idea of a functional unit in which local interactions occur
between a group of retinal neurons and their supportive glial cell
gave rise to the proposal of co-operativity among cells. This idea
was based on developmental studies, where Müller cells were
thought to perform many of the metabolic, ionic and extracellular
buffering requirements of neurons, with which they share a com-
mon progenitor (Turner and Cepko, 1987). Later, an interesting
concept arose suggesting that co-operativity exists among cells that
arise from a common stem cell to form a columnar array
(Reichenbach et al., 1993). The idea is that the retina is constituted
by many functional units in which local interactions occur between
the group of retinal neurons and their supportive Müller glial cell,
limiting the sphere of inﬂuence of the latter. Thus, each Müller cell
may only have to meet the requirements of its immediate neigh-
bours for the extracellular environment to remain stable in the face
of intense neural activity.
In retinal sections, the processes of Müller cells are seen to
ensheath the cell bodies and processes of retinal neurons, espe-
cially after retinal damage (Hernandez et al., 2010). Thus, it seems
likely that the intimate association between these two cell types
Fig. 1. Schematic drawing of the cellular components of the retina: glia and neurons. The different cell types are situated in a standard large mammalian retina. Note the in-
teractions between the cells and blood vessels (BV). Amacrine cells (A), astrocytes in green (AS), bipolar cells (B), cones (C), ganglion cells (G), horizontal cells (H), Müller cells in blue
(M), microglia in red (Mi), rods (R), cones (C). Note the location of the different layers of the retina (from the most internal to the outer layers): optic nerve (ON), nerve ﬁbre layer
(NFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), outer segment layer (OS), pigment
epithelium (PE), choroid (Ch).
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would help maintain neuronal function by providing the nerve
terminals with energy substrates and neurotransmitter precursors
(Pfrieger and Barres, 1996). Ensheathing by Müller cells is only
possible to observe when membrane markers, like low afﬁnity re-
ceptor p75, are used to stain the Müller cells, as it is not evident
with cytoskeletal markers (Fig. 3). As there are no speciﬁc astrocyte
membrane markers, and GFAP (glial ﬁbrillary acidic protein) and
p75 co-localize in bothMüller cells and astrocytes, it is possible that
at least some of the ensheathing membranes around RGCs could
belong to astrocytes. Moreover, in some species like dogs, the RGC
axons are packaged and intercalated between the end feet of
groups of Müller cells on their way to the optic nerve, forming a
nest like structure. By contrast, in species like the pig or minipig,
the RGC axons are intercalated between the Müller cells and such
axonal packages are not found (Fig. 2).
Although Müller cells from different species vary considerably
in shape, they do have some fairly universal features. At the level of
the outer limiting membrane (OLM), two processes extend in
opposite directions and Müller cells extend apical microvilli into
the sub-retinal space between the inner segments of photoreceptor
cells. The length and number of microvilli may vary between spe-
cies, probably in an inverse relationship to the degree of retinal
vascularisation (Uga and Smelser,1973), and in some speciesMüllercells also possess a cilium (Ennis and Kunz, 1986). In the opposite
direction, the inner process approaches the vitreal surface of the
neuroretina, forming a so-called endfoot that abuts the basal lam-
ina between the vitreous body and the neuroretina (the “inner
limiting membrane”, ILM). In the nuclear layers, the lamellar pro-
cesses of Müller cells form structures that envelop the cell bodies of
neuronal cells (Dreher et al., 1992; Hama et al., 1978; Reichenbach
et al., 1988, 1989). In addition, Müller cells are involved in the
structural organization of the blooderetina barrier (Reichenbach
et al., 1995). Blood capillaries are ensheathed by Müller cell pro-
cesses that act as a communication system for metabolic exchange
between the vasculature and neurons, in much the samemanner as
postulated for brain astrocytes (Fig. 2D). However, the close phys-
ical association between Müller cell processes and retinal vessels
still leaves open the possibility that the Müller cell per se is an
essential component of the blooderetina barrier, and as such, it
may be capable of inﬂuencing its own permeability (Sarthy and
Ripps, 2001).
In summary, the Müller cell population accumulates in a dense,
regular pattern, although each cells can be considered as the core of a
columnar retinal “microunit”ofneurons (Reichenbach andRobinson,
1995). This “strategic position” enables Müller cells to constitute an
anatomical and functional link between retinal neurons and the
compartments with which these need to exchange molecules, i.e.:
Fig. 2. Müller cells. A, C and E are from dog retinas, B and D are from pig retinas, and F is from rat. (A) Müller cells are labelled in the retinal pigment epithelium (RPE) with
antibodies against vimentin (red) and RPE65 (green), and the nuclei were stained with DAPI (blue). (B) Retina section stained with antibodies against glutamine synthetase (GS). (C)
High magniﬁcation of a section at the level of the retinal ganglion cell layer (RGCL), labelled with antibodies against vimentin (red), showing the Müller endfeet and RGC axons
labelled with antibodies against neuroﬁlaments (NF) in green. (D) High magniﬁcation of the Müller endfeet stained with antibodies against GS surrounding a blood vessel (BV) at
the nerve ﬁber layer level. (E) Müller cells and RPE of a dog retina section stained with antibodies against CRALB. (F) Rat Müller cells in culture marked with green ﬂuorescent
protein (GFP). Scale bar for all pictures ¼ 50 mm.
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Accordingly,Müller glia fulﬁlmanycrucial roles, supportingneuronal
development, survival and informationprocessing (Reichenbach and
Bringmann, 2010; Sarthy and Ripps, 2001).
2.1.2. Müller cell markers
Müller cells can be easily identiﬁed by their characteristic
morphology, containing a well-developed endoplasmic reticulum
with varying amounts of glycogen granules (Hogan et al., 1971). A
prominent number of mitochondria are found at the endfeet
(Fig. 3). Müller cells can be labelled in living retinal preparations by
loading for a few minutes with vital dyes, such as Mitotracker or-
ange or CellTracker green. Their nuclei can be stained with
ethidium bromide, diamidino yellow or chromomycin A3, whichselectively penetrate Müller cells and have a marked afﬁnity for
nucleic acids (Jeon and Masland, 1993; Laties, 1983). In culture,
Müller cell nuclei can be differentiated, as they are the largest of the
different retinal cell types.
In terms of immunohistochemical markers, the expression of
various proteins is restricted to astrocytes and Müller cells, like
vimentin and glial ﬁbrillary acidic protein (GFAP), or selectively to
Müller cells, such as the cellular retinaldehyde-binding protein
(CRALBP), the glutamate-aspartate transporter (GLAST), glutamine
synthetase (GS), the Kir4.1 subtype of inwardly rectifying potas-
sium channels, aquaporin-4 (AQ4), pyruvate carboxylase, a-crys-
tallin, the small GTP-binding protein RhoB, glutamate
carboxypeptidase II, carbonic anhydrase C and microtubule-
associated protein 4 (Berger et al., 1999; Bunt-Milam and Saari,
Fig. 3. Interactions between Müller cells and Retinal Ganglion cells (RGCs). (A) Retina section where RGCs are labelled with antibodies against ßIII Tubulin (green) and Müller cells
are labelled with antibodies against GFAP (red). (B) Electron microscopy detail of mitochondria in the interior of the Müller cell endfeet. (C) Retina section where the RGC are
labelled with antibodies against BDNF (green) and Müller cell membranes with antibodies against p75 (red). Note that RGCs were enveloped by p75-labelled Müller processes. (D)
Electron microscopy detail of RGC (G) wrapped in Müller cell processes (M). Scale bar A), C), D) ¼ 10 mm, B) ¼ 1 mm.
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et al., 1985; Santos-Bredariol et al., 2006).
2.2. Astrocytes
2.2.1. Origin and morphology of astrocytes
Named on the basis of their stellate shape, astrocytes are almost
exclusively conﬁned to the innermost retinal layers. The astrocytes
in the retina do not originate from the retinal embryonic epithe-
lium and thus, it is generally believed that these astrocytes migrate
from the optic nerve and probably enter the retina along with the
blood vessels (Stone and Dreher, 1987; Turner and Cepko, 1987;
Watanabe and Raff, 1988). In the optic nerve, as in other white
matter tracts, most astrocytes and oligodendrocytes are derived
from local mitoses (Skoff, 1990). The ventricular cavity disappears
in the evagination that forms the retina and optic nerve, and it is
believed that the mitotic precursors of the oligodendrocytes and
astrocytes migrate into the optic nerve from the sub-ependymal
germinal layer of the brain. According to the extent of myelina-
tion, there would appear to be species differences in the migration
of oligodendrocyte precursors. Thus, myelination stops at the
lamina cribosa in the human and rat, while in rabbit and dog
myelination extends beyond the lamina cribosa to reach the optic
nerve head. In some ﬁsh, where the lamina cribosa is absent,
myelination extends into the retina within the optic ﬁbre layer
(Wolburg, 1981).
The presence and distribution of retinal astrocytes is correlated
with the presence and distribution of retina blood vessels (Fig. 4).
Thus, while avascular retinas contain no astrocytes, they aredistributed diffusely in those that are diffusely vascularized and
restricted to the vascularised regions of other retinas. This striking
correlation between vascularisation and the presence of astrocytes
led to the proposal that retinal astrocytes are immigrants that enter
the retina with its vasculature. While astrocytes may reside in
almost all regions of the retina, regional differences in their density
arise. Astrocytes are absent in retinal regions with extremely thin
nerve ﬁbre layers, such as areas near the ora serrata, and they are
absent from the fovea centralis and the peri-foveolar retina of
primates. Moreover, the periphery of the retina has a thin nerve
ﬁbre layer and it contains only a few dispersed astrocytes, the
number of which increases as the nerve ﬁbre layer thickens. As-
trocytes send processes to both blood vessels and axons. Two
groups of astrocytes can be distinguished in the pig and minipig
retinas, those that are directly connected with blood vessels and
those that seem to be connected with RGC axons. We found elon-
gated astrocytes and star-shaped astrocytes similar to those ﬁrst
described in primates by Ogden (1978). By contrast, in rat and mice
we only found star-shaped astrocytes as described in other species
(Fig. 5).
The numbers and distribution of astrocytes depends on the
density of the nerve ﬁbres that they ensheath, as conﬁrmed by
confocal microscopy and computer-assisted image reconstruction
of astrocytes in the vascularised retina of pigs, rats and mice
(Rungger-Brandle et al., 1993), and in the disposition of astrocytes
between species (Fig. 5). For example, in the fully vascularised
retina of cat, astrocytes are distributed throughout the inner retina
in a pattern that closely mirrors that of the axon bundles (Karschin
et al., 1986). The reconstruction of images from retinas stained for
Fig. 4. Astrocytes. (A) Minipig retinal section. RGCs are labelled with antibodies
against ßIII Tubulin (green), Müller cells and astrocytes are labelled with antibodies
against GFAP (red) and the nuclei are stained with DAPI. Note that the astrocytes follow
the blood vessels from the RGC layer to the outer nuclear layer (ONL). (B) Confocal
image of a rat whole-mount rat retina where astrocytes were labelled with antibodies
against GFAP (green) and aquaporin 4 (AQ4, red) (C) Rat glia primary culture. Astro-
cytes are indicated with an arrowhead, while the other cells are Müller cells with a
larger nuclei: vimentin labelling (green) and nuclei are stained with DAPI. Scale
bar ¼ 50 mm.
E. Vecino et al. / Progress in Retinal and Eye Research 51 (2016) 1e40 7GFAP (astrocytes) allowed us to visualize the ensheathing of blood
vessels (Figs. 4B and 5A), whereby the vitreal and lateral sides of
most blood vessels are in close apposition to the vitreal surface of
the retina. In addition, individual astrocytes can be seen to extend
their processes into the vessel wall in such confocal images, espe-
cially in pig retinas, and while in some instances astrocytic pro-
cesses extend to the vitreo-retinal surface, in other cases astrocytes
remain parallel to RGC axons. It is noteworthy that astrocytes
communicate by gap junctions, and that both vitreous and blood
vessels can serve as a “sink” for Kþ (Newman et al., 1984).
2.2.2. Astrocyte markers
Astrocytic process envelops blood vessels as seen in electron
microscopy, with apparently no perivascular space between the
adventitia of the vessel wall and the glial cells (Hogan and Feeney,
1963; Hogan et al., 1971). GFAP is the major constituent of the
astrocytic intermediate ﬁlament (Bignami et al., 1972), and it rep-
resents a reliable marker to identify and localise astrocytes in the
mammalian retina. Under normal circumstances macroglia and
mammalian Müller cells contain signiﬁcant amounts of GFAP and
thus, astrocytes must be classiﬁed as one of two distinct types in
the retina by attending to other molecular markers: type I astro-
cytes express GFAP and connexin-43. Whereas type II astrocytesexpress GFAP but not connexin-43. Type I astrocytes can be further
divided into type Ia and type Ib, the former present in the optic
nerve head while type Ib astrocytes are present in the ILM of the
retina (Hernandez et al., 2000). Interestingly, both types are
quiescent astrocytes and they only become reactive in response to
certain stimuli, including elevated intraocular pressure, excitotox-
icity and retinal ischemia (Hernandez et al., 2008).When astrocytes
become reactive they hypertrophy and enlarge their soma, they
develop thicker astrocytic processes and their GFAP-
immunoreactivity is enhanced.
2.2.3. Astrocytes main functions
Despite our increased understanding of the function of inter-
mediate ﬁlaments (IFs) in astroglial cells (for a review, see Pekny,
2001), the role of astroglial IFs in maintaining the mechanical
integrity of these cells and that of the CNS tissue remains unclear.
As the main producers of VEGF (vascular endothelial growth factor)
during both normal (Stone et al., 1995) and pathological (Ozaki
et al., 2000) vessel formation, astroglial cells are strongly impli-
cated in retinal vascularisation. However, the vascular system de-
velops normally in GFAPe/e;Vime/e mice, and VEGF RNA is
expressed at normal levels in both ischemic and control GFAPe/
e;Vime/e retinas, indicating that the absence of IFs in astroglial cells
does not affect their role in retinal vascularisation, either in healthy
or pathological conditions. The absence of IFs in astrocytes does not
impede the production of chondroitin sulphate proteoglycans, yet
it might delay the onset of astrocyte maturation and prolong the
window for optic nerve regeneration in GFAPe/e; Vime/e mice.
These data support the hypothesis that mature astrocytes represent
a key barrier to CNS axon regeneration in vivo (Cho et al., 2005) and
thus, astrocytes may play dual roles: one beneﬁcial and another
degenerative.
Some of the beneﬁcial roles fulﬁlled by astrocytes include
neurotrophic support, enhanced mechanical support for degener-
ating axons, and the maintenance of the blooderetina barrier. In
response to injury or disease, the same astrocytes express a number
of proteins that compromise the integrity of blooderetina barrier,
up-regulating the expression of various genes encoding cytokines,
chemokines and elements of the complement cascade, and pro-
moting retinal degeneration (Anderson et al., 1967; Kim et al.,
2006). Reactive astrocytes in the retina express increased levels
of MMP-9 and uPA, and accordingly, they degrade the extracellular
matrix associated with the ILM and they promote RGC death via
detachment-induced apoptosis (Zhang et al., 2004). In the different
sections that follow, we will refer to many other functions of as-
trocytes in more detail.
2.3. Microglial cells
Experimental evidence has conﬁrmed the so called immune
privilege of the CNS on the basis of the existence of the bloodebrain
barrier (BBB), the absence of lymph or the lack of locally competent
macrophages. However, more recent research supports the notion
that the CNS establishes robust interactions with the immune
system and that the microglia fulﬁls a key role in controlling im-
mune responses (Carson et al., 2006). The CNS reacts through im-
mune responses that are both innate and adaptive, and that are
mediated by distinct populations of immune competent cells.
These cells may or may not share their embryonic origin but they
communicate through direct contact and paracrine interactions.
Microglia, astrocytes, inﬁltrating T-cells and macrophages form a
complex and pleiotropic defence network that secures and protects
the integrity of the CNS (Colton, 2009; Corraliza, 2014; Prinz and
Priller, 2014; Ransohoff and Brown, 2012).
Macrophages are a morphologically and functionally diverse
Fig. 5. Whole mount retinal explants. A, and C are control retinas. B and D are explants. A and B are pig retinas. C and D are mouse retinas. The astrocytes are labelled with
antibodies against GFAP (red in pig, A and B, and green in mouse, C and D). Note the changes in the astrocyte morphology between control and explant retinas. Scale bar ¼ 50 mm.
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differentiation, tissue localization, and exposure to both internal or
external stimuli (Gordon, 2003; Gordon and Martinez, 2010; Prinz
and Priller, 2014). The macrophage family includes meningeal and
perivascular macrophages, blood circulating macrophages, den-
dritic cells derived from the bone marrow, and tissue resident
macrophages (Wieghofer et al., 2014). The microglia form a popu-
lation of resident macrophages within the CNS that not only has
immune activity but also, that participates in the development and
maintenance of neural networks, as well as in tissue homeostasis
(Fernandes et al., 2014; Gertig and Hanisch, 2014; Ransohoff and
Brown, 2012). Although the origin of these cells is controversial,
it is believed that primitive myeloid progenitors of the egg sac are
the precursors of these cells and not the bone marrow (Ginhoux
et al., 2010; Schulz et al., 2012), and during adulthood a popula-
tion of local progenitors ensures the continuity of the microglia in
the nervous system (Ajami et al., 2007). Microglia have a quite
speciﬁc morphology and physiology, very different from their
precursors, and they adapt to their neural environment to fulﬁl
their designated roles (Kettenmann et al., 2013).
As occurs with many advances in science (over time and
through persistence), the morphological and functional deﬁnition
of microglia has gradually been sculpted (Ginhoux et al., 2013). The
term “mesoglia” was proposed by Robertson (Ginhoux et al., 2013;
Kettenmann et al., 2013). Del Rio-Hortega in a conference delivered
in 1938 at the University of Oxford (UK), deﬁned microglia as the
non-neuronal and non-astrocytic component of the “third
element”, of mesodermal origin, that can change its phenotype,
migrate and proliferate. He also separated microglia from the
oligodendroglia (Del Rio-Hortega, 1939), a characterization that can
still be applied today. Their plastic nature makes deﬁning the
functional phenotypes of microglia difﬁcult. However, it seems
clear that microglia can exist in different states of activation and
“quiescence”. Indeed, there seems to be a spectrum of intermediate
states or functional phenotypes that may explain their complex
physiology (Cherry et al., 2014). For instance, when using artiﬁcialmicrostructured supports in vitro, these cells demonstrate a high
degree of plasticity in distinct extracellular milieus (Amadio et al.,
2013).
2.3.1. Origin, morphology and distribution of microglia
Several cell pools of myeloid origin and with commonmolecular
features populate the CNS, although they also exhibit important
differences relating to their origin and activity. Experiments in mice
conﬁrmed that microglia originate in the yolk sac at an early stage
of embryonic development, between 8.5 and 9.5 days post-
fertilisation (dpf) (Ginhoux et al., 2010; Schulz et al., 2012). Spe-
ciﬁcally, they derive from erythromyeloid precursors (Kierdorf
et al., 2013). These stem cells undergo a sequential development
from stage A1 when they express the CD45 antigen to stage A2,
when they synthesize myeloid markers that include CX3CR1
(chemokine receptor 1) and CSF1R (colony-stimulating factor 1
receptor). Stage A2 cells migrate to the brain parenchyma with the
aid of speciﬁc matrix metalloproteinases (MMPs), where they
establish their ﬁnal destination (Kierdorf et al., 2013; Prinz and
Priller, 2014; Prinz et al., 2011). By contrast, other macrophage
populations that inhabit the CNS have different myeloid origins,
which include the fetal liver, the aortaegonademesonephros re-
gion and the bone marrow (Kierdorf et al., 2013; Prinz and Priller,
2014).
Microglia colonise CNS structures during embryogenesis and in
the early postnatal period until they reach their positions in the
mature brain (Harry, 2013). Colonization occurs along different
migratory pathways, following glial structures, white matter net-
works or blood vessels (Rezaie and Male, 1999). In the CNS,
microglia are distributed widely in the gray and white matter, and
they present local singularities related to their function (Harry,
2013). The diverse morphologies of the microglia are related to
their activation states or functional phenotypes (Kettenmann et al.,
2011). Brieﬂy, in the so called “resting” state they have a ramiﬁed
appearance with a small cell body and rather large nucleus. In the
“activated state” the cell morphology is more ameboid and they
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microglia are found at variable densities in the different retinal
layers, including the NFL, ganglion cell layer (GCL), inner plexiform
layer (IPL), inner nuclear layer (INL) and OPL (Chen et al., 2014;
Cuenca et al., 2014; Garcia-Valenzuela et al., 2005; Noailles et al.,
2014; Santiago et al., 2014; Sobrado-Calvo et al., 2007). The cells
have a small ovoid-shaped cell body and multiple ramiﬁcations in
the GCL of the normal retina, and they are organized into a single
sheet that is distributed homogeneously (Garcia-Valenzuela et al.,
2005). In the optic nerve, microglia ramiﬁcations appear to be
orientated along the ﬁbres. This orientation is disorganized in an
experimental model of diabetes (Chen et al., 2014), and the distri-
bution and organization of microglia within the retinal layers is
altered in a variety of pathological states, when changes in cell
shape can be observed (Cuenca et al., 2014; Kezic et al., 2013).
Moreover, when RGCs are labelled with a retrograde vital ﬂuores-
cent dye in an experimental axotomy, microglia containing RGC
debris can be detected months after the injection of marker, indi-
cating both the phagocytotic capacity of microglia and their relative
longevity (Thanos et al., 1994).2.3.2. Plasticity and functional microglia phenotypes
Microglia fulﬁl specialized immune tasks, responding to speciﬁc
stimuli by secreting cytokines and neurotrophic factors. In addition,
they establish a close relationship with neurons and other cells so
that they contribute to the remodelling of neuronal circuits, as well
as to the elimination of cell debris and deranged synapses. Micro-
glia also play a role in pathological events that affect the CNS
(Kettenmann et al., 2013; Prinz et al., 2011; Wieghofer et al., 2014).
Microglia exist in two separate morphological/physiological states,
namely “resting” and “activated” microglia (see for instance Colton,
2009; Kettenmann et al., 2011, 2013; Ransohoff and Perry, 2009). InFig. 6. Microglia. (A) Pig retina section where the microglia were labelled with antibodies
against GFAP and the nuclei were stained with DAPI. (B) Ampliﬁcation of A, where the ﬁlled a
of A where the empty arrowhead indicates the interaction between a microglial cell and a
with mitotrack (red) and the nuclei are stained with DAPI. Scale bar ¼ 50 mm.his early studies, Del Rio Hortega observed these two different
morphologies and he related them to the primitive invasion of
microglia (amoeboid) and the pool of settled cells in the mature
brain (branched and ramiﬁed: (Del Rio-Hortega, 1939). However,
although these two states serve as a reference point, the adaptable
and ﬁne-tuned responses of microglia reinforce the existence of
several intermediate and fully functional phenotypes (Cherry et al.,
2014). One basic response of microglia to local insults depends on
the presence of extracellular ATP and it involves the speciﬁc
extension of microglial processes to the injured site (Davalos et al.,
2005). This morphologicalephysiological tour has been called the
“spider effect” (the spider in the middle of the web responds to
vibration caused by the “intruder” and moves to the site where the
prey is trapped, thereafter returning to its “vigilant” site in the
middle of theweb: (Jonas et al., 2012). The concept of “resting” state
implies an “inactive” condition and it may lead to confusion, since it
suggests a passive behaviour that would only be converted to an
“active”, functional state under certain circumstances (for example,
infection, malignancy, trauma, neurodegeneration, etc…). Experi-
mental studies support the idea that even in healthy and homeo-
static conditions, microglia are responsive to changes in the
environment, and that they modulate numerous events by
secreting cytokines and other factors, and by interacting with other
glial cells and neurons (Kettenmann et al., 2011; Wieghofer et al.,
2014). Therefore, applying the term “surveying” instead of
“resting” to vigilant microglia seems to be more appropriate
(Santiago et al., 2014) (Fig. 6).2.3.3. Representative molecular traits of microglia
Microglia produce many substances and they also have receptor
systems that process chemical signals from neighbouring or distant
cells. The complex physiology of microglia relies on their secretoryagainst Iba-1 (red), astrocytes and Müller cells (green) were labelled with antibodies
rrowhead indicates a microglia cell around an astrocyte or Müller cell. (C) Ampliﬁcation
blood vessel. (D) Rat microglia primary culture where the mitochondria were labelled
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neurotransmitters and neuromodulators (e.g., dopamine, GABA,
glutamate, epinephrine/norepinephrine, cannabinoids, histamine,
angiotensin II, opioids, bradykinin, neurotrophins, acetylcholine,
etc…); cytokines and chemokines, including TNF-a (tumour ne-
crosis factor) or interleukins; complement; epidermal growth fac-
tor (EGF); Notch; macrophage colony-stimulating factor; peptides;
leukotrienes…etc. Microglia also express different transporter
systems for solutes and ions (Kettenmann et al., 2011).
Microglia communicate with other glial cells and neurons by
secreting factors that establish speciﬁc secretory signatures char-
acteristic of distinct functional or pathological states. The mole-
cules secreted bymicroglia and other glial cells (both proteinaceous
and non-proteinaceous) are deﬁned as their secretome, and
establishing its composition may be essential to discover bio-
markers useful for diagnosis and prognosis, as well as in the search
for new therapies to alleviate different CNS pathologies. Here we
name just a few of the molecules that microglia are known to
secrete, either constitutively or in response to inﬂammation, injury,
CNS development and degeneration or homeostasis: cytokines and
chemokines, ROS (reactive oxygen species), nitric oxide (NO),
phospholipase A2 IIA type, BDNF (brain-derived neurotrophic fac-
tor), GDNF (glial cell line-derived neurotrophic factor), IGF (insulin-
like growth factor), FGF-2 (ﬁbroblast growth factor 2) or LC1 (lip-
ocortin 1) (Jha et al., 2013). Cell contacts and soluble factors are key
elements to maintain the functional dialogue established between
the different cell types that populate the retina and they are char-
acteristic of a given activation state of microglia (Langmann, 2007).
A representative example of a neuronemicroglia interaction is the
FKN/CX3CR1 system (fractalkine or CX3CL1 and its G protein-
coupled receptor, CX3CR1). Fractalkine is a chemokine that may
exist as a membrane-bound protein or in a soluble form, and it is
present in neurons that bind to CX3CR1 expressed on microglia.
The CX3CL1 ligand modulates the activation of microglia in distinct
manners during homeostasis and in disease states (Sheridan and
Murphy, 2013). In the retina, the action of CX3CL1 depends on
the conversion of the membrane-bound and soluble isoforms, and
it participates in both neurogenesis and the response to cues that
trigger neurodegeneration (Zieger et al., 2014). Microglia also ex-
press adenosine receptors that regulate their activities both in
healthy and disease states (Santiago et al., 2014). Accordingly,
microglial receptor proteins appear as important targets for the
development of drugs to prevent or manage retinal neuro-
inﬂammation. The secretory capacity of microglia depends on non-
vesicular (transporters or ion channels) and vesicular mechanisms,
such as exocytosis and the release of extracellular membrane
microvesicles (EMVs) loaded with bioactive molecules (Prada et al.,
2013).
2.3.4. Identiﬁcation of microglia
Due to the important role of microglia, both in homeostasis and
disease, it is of particular interest to develop tools to characterize
and identify these cells, as well as the molecular dialogue they
undertake in their multiple modulatory activities. This task is
difﬁcult, particularly since this group of cells share molecular
identities with related cells of hematopoietic origin (Wieghofer
et al., 2014). The identiﬁcation of cells is based on their localiza-
tion and morphology, as well as on the speciﬁc expression of sur-
face proteins and the functions associated to them. The
methodological approaches may involve the use of speciﬁc anti-
bodies to localize protein epitopes (immunocytochemistry, western
blotting…) or the manipulation of gene expression. The identity of
microglia can be assessed by using different protein markers (for
instance, IBA-1, ED-1, HLA-DR, CD-45…etc). In most cases, the
antibody markers (such as IBA-1 -ionized calcium binding adaptormolecule 1- and ED-1 -monoclonal antibody against glycoprotein
CD68) can be used simultaneously to differentiate microglia from
other cell-related populations, including migrating macrophages
(Ellis-Behnke et al., 2013). Since all types of macrophages and
microglia express the F4/80 protein (a surface receptor of the EGF
family), this marker alone is not suitable to target microglia. His-
tochemical detection also offers advantages in some cases. For
instance, one histochemical method uses a tomato lectin with af-
ﬁnity for sugar moieties present on microglial and endothelial cells,
allowing the relationship of microglia with blood vessels to be
analysed (Villacampa et al., 2013). Microglia in different activation
states can be characterized using combinations of techniques
aimed at analyzing the secretory, proteomic and transcriptional
signatures (Glanzer et al., 2007): microarrays, real-time RT-PCR
(reverse transcription polymerase chain reaction), SELDI-TOF (sur-
face-enhanced laser desorption ionization-time of ﬂight), two-
dimensional gel electrophoresis (2D-PAGE), mass spectrometry,
quantitative western blotting…etc.
Genetic manipulation serves to target microglia and has pro-
vided relevant tools to distinguish these cells from other myeloid
cells. Different approaches are available and include labelling
methods (where ﬂuorescent reporter genes like GFP -green ﬂuo-
rescent protein- or LacZ -beta-galactosidase- may help to monitor
the spatio-temporal expression of a given protein), as well as the
manipulation (activation and deletion) of genes that produce stable
transgenic animal lines (see Wieghofer et al., 2014 for a review). On
occasions it is difﬁcult to separate macrophage populations and to
assign the speciﬁc involvement of each class to particular functions.
In a knock-in mouse model, where CNS microglia were labelled
with a GFP-tagged CX3CR1 and blood originated monocytes were
labelled with a RFP (red ﬂuorescent protein)-tagged CCR2, the ge-
netic markers allowed “red” inﬁltrating monocytes and “green”
resident macrophages to be visualized (Saederup et al., 2010). This
method has also been applied to localize microglial populations
during development and at their ﬁnal sites (Mizutani et al., 2012).
Based on the self-renewal capacity and the long lifespan of
microglia, a genetic system has been developed where the
expression of Cre recombinase (an enzyme that catalyzes site-
speciﬁc DNA recombination events) is controlled by the promoter
of a gene that encodes Cx3cr1 (Goldmann et al., 2013). This
experimental system allowed an in vivo animal model to be elab-
orated (Cx3cr1Cre mouse) in which conditional depletion of a
mitogen-associated protein kinase kinase kinase (MAPK3), TAK1
(transforming growth factor b-activated kinase 1), demonstrated
the direct participation of microglia in autoimmune inﬂammation.
This model opens new avenues to ascertain the role of different
genes expressed in microglia at speciﬁc time points or under spe-
ciﬁc circumstances (physiological or pathological). Since many
diverse techniques are available, it is important to be aware of the
potential and the limitations of each of these when designing ex-
periments to study the presence, morphology and function of
microglia.3. Common functions of different glial cells in the retina
The three glial cell subtypes present in the retina share many
properties that while possibly redundant they have a preferential
hierarchy in which they are performed. There are certain functions
of retina glial cells that are more predominant in one cell type or
another. Thus, in the following sections we will review the most
recent advances related to this important issue and the role of these
glial cells in maintaining retinal homeostasis.
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Müller cells share many properties with astrocytes, including
the ability to ensheath axons, and to form glial boundaries between
the retina and the blood vessels (Hollander et al., 1991). However,
while Müller cells are formed in the retina, astrocytes migrate
independently of vessels and they are therefore in a position to
respond to environmental signals in avascular areas of the retina.
Their restriction to the inner layer of retina enables them to
respond to hypoxia in this region by expressing VEGF, thereby
inducing the formation of a superﬁcial layer of blood vessels. By
contrast, Müller cells extend across all retina layers and cannot
respond in a layer-speciﬁc manner. The migration of astrocytes
across the surface of the retina therefore provides a population of
macroglial cells that is strategically located to sense hypoxia in the
inner layers of retina.
In addition to the glia limitans of the retina and vessels, astro-
cytes and Müller cells both contribute to the glial sheaths around
neurons. In particular, both astrocytes and Müller cells wrap gan-
glion cell axons into bundles, contributing to the glial convergence
on the initial segments and node-like axon structures, and they also
ensheath the somas of neurons in the RGC layer. Furthermore,
adherens junctions form between astrocytes, between Müller cells,
and between astrocytes and Müller cells, although not between
these cells and neurons or among neurons. These similarities point
to the possibility that astrocytes and Müller cells might act inter-
changeably in some processes, and we propose that they be
regarded as variants of macroglia. Quantitative differences between
astrocytes and Müller cells were noted in their ensheathment of
neurons. Speciﬁcally, the glial sheaths around the somas of RGCs
are predominantly formed byMüller cells (Fig. 3A,C), while the glial
processes attached to node-like specialisations of their axons are
mainly formed by astrocytes (Fig. 5A: Stone et al., 1995). In dog
retinas in particular we found that axons form packages that
interdigitate between the endfeet of the Müller cells in way similar
to the nests building (Fig. 2C).
One qualitative difference has been that in two glial cell classes
the gap junctions formed between astrocytes do not form between
Müller cells or between these two different types of cells. Thus, the
roles of the two types of glial cells, in terms of the information and
communication related to the cells that are ensheathed could vary.
Moreover, reactive astrocytes form a border between the lesion and
the surrounding tissues, and as resting microglia are located in
certain areas, close to where the retina is vascularised, they form an
imaginary fence that limits the penetration of any invader into the
retina.
3.2. Glia as a structural support for neurons
3.2.1. Viscoelastic properties
The biomechanical changes in the retina during its development
and in disease are very important, and they could be the underlying
cause of several conditions. During development and after the optic
vesicle has closed, the intraocular pressure and proliferation of
neuroblasts causes the primitive retina to stretch. After birth, the
retina continues to expand tangentially, stretching out from the
centre to periphery until the eye reaches a maximum size. During
this growth period the components of the retina must be elastic.
The retinal neurons are signiﬁcantly stiffer than the glial cells, and
elasticity decreases from the inner to the outer retina. Moreover,
the two limiting membranes of the retina are stiffer that the rest of
the layers. While the Müller cell endfeet, nerve ﬁbre bundles and
GC somata are stiff structures, the least elastic part of the retina is
the ONL as well as the inner and outer photoreceptor segments
(Franze et al., 2011; Lu et al., 2006). The elastic stiffness of retinalMüller glial cells does not vary remarkably in the different
mammalian species studied so far (Lu et al., 2013), and their
viscoelastic properties appear to be similar in man, monkey and rat.
In general, their elastic behaviour dominates over their viscous
behaviour.
Müller cells act as mechanosensors, as they span vertically from
the inner to the outer retina. The Müller cells form stiff endfeet that
are rich in mechanosensitive ion channels, indicating that the
biomechanical responsive element of the retina is located in this
region. In addition to the different types of cells, the mechanical
properties of soft tissues like the retina mainly depend on extra-
cellular matrix components like collagen, elastin and pro-
teoglycans. One of the main functions of proteoglycans is to retain
water, which constitutes >70% of the retina. The presence of water
in tissues causes collagen ﬁbres to separate, swell and become
disorganized, which signiﬁcantly affects their relative stiffness and
tensile strength (Chen et al., 2009a).
The biomechanical scaffolding of the retina, as well as its
biochemical homeostasis, is maintained by Müller cells and astro-
cytes. These cells can alter their elasticity and stiffness by up- and
downregulating their IF proteins, the most common of which are
GFAP and vimentin, thereby altering both the tissue-wide and
cellular biomechanics of the retina (Bringmann et al., 2009a;
Lindqvist et al., 2010; Lu et al., 2011). In mice lacking GFAP and
vimentin, mechanical challenge revealed an exaggerated fragility of
Müller cells (Lundkvis et al., 2004). Müller cells are mechanically
heterogeneous in the lateral direction, although they seem to
display a mechanical homogeneity in the vertical direction. Due to
the distinct cytoskeletal organization in local regions of a Müller
cell, the regions closer to the endfeet, soma and processes can be
discerned by their mechanical properties (Lu et al., 2006). This local
variation in the mechanical compliance of a single Müller cell is
likely to determine the mechanical diversity in the retina (Park and
Lee, 2013). Mechanosensory Ca2þ ion channels, such as TRPV4, are
known to be present on Müller cells, particularly on the Müller cell
endfeet at the inner retinal border. Thus, these channels may also
provide the retina with a sensor of biomechanical changes
(Ryskamp et al., 2011).
In normal situations, in addition to morphological alterations
due to glutamatergic neurotransmission, there are traction forces
on Müller cells in the retina derived from the vitreous body. In the
human retina, the vitreous body adheres to the retinal tissue at the
peripheral retina through themajor superﬁcial retinal vessels, optic
disc, perifovea and macula. At sites of vitreo-retinal attachments,
the basement membrane of the ILM can become thinner, and vit-
reous ﬁbres can adhere directly to Müller cells (Schubert, 1989).
However, there is limited information regarding the biomechanical
properties of these cells (and of the retinal tissue). Experimental
approaches are limited as it is unclear whether retinal cells and the
tissue of laboratory animals suitably reﬂect human conditions (Lu
et al., 2013).
Astrocytes are abundant in the CNS, and their role as passive
nurturing cells has been broadened to a more dynamic function in
terms of their relationship with other glial cells and neurons.
Because of the specialized nature of astrocytes, their morphology
and their location in the retina, one might envision that astrocytes
in the retina may contain mechanical sensors. Accordingly, astro-
cytes might sense eye movements and other perturbations of the
retina, for example an elevation of the intraocular pressure. Little is
known about the indicators of the mechanical state, however it has
been proposed that astrocytes at the optic nerve head could induce
astrocytic signalling by releasing ATP (Barres and Dowling, 2010). If
this was to occur, ATP release could potentially stimulate microglial
cells to migrate to the nerve head, activating astrocytes to become
reactive and inﬂuence neurons or blood ﬂow (Barres and Dowling,
Fig. 7. Changes in the distribution of BDNF and p75 receptors in control rat retinas and following ischemia. (A, C, E, G) Retinal sections where RGCs were labelled with antibodies
against BDNF. (B, D, F, H) Müller cells labelled with antibodies against p75 receptor. (A, B, E, F) are control retinas and (C, D, G, H) are the contralateral retinas where the ischemic
insult was maintained for 1 h, followed by 2 (C and D) or 24 h of reperfusion (G and H). Note the increase in immunoﬂuorescence staining within the ganglion cell layer of C
compared to the control (white arrows) A, and the decrease in labelling in G as compared to E. Note the loss of the layering of Müller cells stained with antibodies against p75 in H
compared to F. Scale bar ¼ 50 mm.
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reactive gliosis, which might perturb their vasodilatory role by
disrupting their vessel contacts and interfering with their gap
junction coupling. Alternatively, this response could perturb the
ionic homeostasis, since astrocytes are also vulnerable to neuronal
death (Cahoy et al., 2008; Foo et al., 2011).3.2.2. Architecture-mechanical forces
The axons within the retina of all species are organized radially
in order to converge at the optic nerve head, yet there are impor-
tant differences in the way that astrocytes are distributed within
the retina. While in the pig, minipig and human, astrocytes are
organized in two levels onemore vitreal and anothermore internal.
The more vitreal astrocytes have a parallel disposition that can be
observed in ﬂat mount retinas (Fig. 5A), while in rat and mice, the
distribution of astrocytes is more stellate appearance and their
extensions do not run parallel to the optic nerve (Figs. 4B and 5C).
Astrocytes can modify their distribution in response to local
changes and thus, after axotomy and explant culture the pattern of
astrocytes observed in ﬂat mount retinas is lost within a few days. It
is possible that astrocytes sense the damage to the axons and thus,
they tend to lose their contacts and redistribute within the retina.
In mice and rats, astrocytes became hypertrophic and assume a
stellate shape, as observed in glaucoma (Fig. 5).
Müller cells also sense the changes that take place in the inner
and outer retina (see below, “glaucoma and retinitis”). Müller cells
modulate neuronal activity by regulating the concentration of
neuroactive substances and potassium in the extracellular space
through a variety of transport processes (Newman and
Reichenbach, 1996). This activity of Müller cells is particularly
important in ischemia when there is a massive release oftransmitters from neurons (Hossmann, 1993). The plastic changes
of the Müller cells take place over a relative short timescale (Fig. 7).
The three distinct layers of immunoreactivity originating from the
extensions of the Müller cells, that are present in the IPL of control
retinas, was no longer evident, rather, it appeared as a single thick
layer after ischemia (Fig. 7F, H).
The communication between Müller cells and RGCs remains
unknown, although we did observe changes to Müller cells in ret-
inas from animals with experimental glaucoma or axotomy
(Hernandez et al., 2009).3.3. Volume regulation
The regulation of cell volume is of great importance to avoid
changes in neuronal excitability resulting from a decrease in the
volume of the extracellular space. Cell swelling and subsequent
Regulatory Volume Decrease (RVD) is accompanied by trans-
membrane potential (Vm) depolarization followed by repolariza-
tion. However, this RVD response depends closely on the
composition of the extracellular media. Although Kþ and Cl
channels play an important role in the RVD response of Müller cells,
their contribution is evident only if a signiﬁcant driving force for
KCl efﬂux is present (Fernandez et al., 2013). The changes in volume
of glial cells are also associated to the viscoelastic characteristics of
the retina.
It has been suggested that Müller cells possess endogenous cell
volume-regulatory mechanisms that are involved in the activity-
dependent regulation of the volume of the extracellular space
(Vogler et al., 2013). In addition to Kir (inwardly rectifying potas-
sium) channel mediated cell volume regulation, Müller cells
possess receptor-mediated mechanisms that prevent hypoosmotic
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pharmacological blockade of Kir channels causes swelling in brain
astroglial somata and processes, yet it has no effect on Müller cells.
The blockade of Kir channels in hypoosmotic conditions induces
immediate swelling of Müller cell somata but no additional
swelling in somata of brain astrocytes (Hirrlinger et al., 2008).
Water accumulation in retinal neurons and glial cells is a patho-
genic factor involved in retinal degeneration under ischemic-
hypoxic and inﬂammatory conditions. Nerve growth factor (NGF)
prevents the osmotic swelling of Müller cells by inducing auto-
crine/paracrine FGF signalling, as well as indirectly controlling the
swelling of bipolar cells by inducing a release of cytokines from
Müller cells (Garcia et al., 2014).
Müller cells of the rodent retina possess a volume-regulatory
glutamatergicepurinergic signal transduction cascade. Glutamate
induces the swelling of inner retinal neurons and shrinkage of the
extracellular space. Retinal glial cells rapidly and signiﬁcantly
change their shape when glutamate is applied to retinal whole
mounts, and this effect is induced by glutamate-evoked neuronal
cell swelling (Uckermann et al., 2004; Wurm et al., 2008b). Müller
cells adapt their morphology to the increased size of activated
retinal neurons by extending and thinning the inner stem process.
This response is due to the opening of potassium and chloride
channels, whereby the ion efﬂux compensates for the osmotic
gradient across the Müller cell membrane and prevents cellular
swelling (Uckermann et al., 2006). The glial water channel
aquaporin-4 (AQP4) is implicated in the control of ion and osmo-
homeostasis in the retina. The water ﬂux through AQP4 is
involved in the rapid volume regulation of retinal Müller cells in
response to osmotic stress and deletion of AQP4 results in an in-
ﬂammatory response of the retinal tissue (Pannicke et al., 2010).
Müller cells can maintain the integrity of the blooderetina
barrier and clear metabolic waste by regulating the homeostasis of
extracellular pH and Kþ ions. To avoid high Kþ levels that might
induce depolarization of retinal neurons, Müller cells take up
excess Kþ from the extracellular space (especially in the synaptic
layers of the retina), and release it into the blood and vitreous
humour (Reichenbach and Bringmann, 2013; Reichenbach et al.,
2007). Many of the homeostatic functions of Müller cells,
including spatial potassium buffering and neurotransmitter uptake,
depend on the negative membrane potential (around 80 mV)
established by the ample expression of Kir4.1 in these cells, which
can regulate and compensate the osmotic conditions (Bringmann
et al., 2006; Kofuji et al., 2000). Kir 2.1 and Kir 4.1 channels were
recently studied under hypoxic conditions, which produced no
signiﬁcant changes in their mRNA expression (Kang et al., 2013).
Adenosine might upregulate the expression of Kir 4.1 channels
while it only weakly affects the expression of Kir 2.1 channels
in vitro. Such upregulation of Kir 4.1 channels should accelerate
retinal Kþ clearance to prevent neuronal hyperexcitation and
excessive release of glutamate (Yu et al., 2012).
AQP4 are present in the plasma membranes of astrocytes that
are in contact with micro vessels (Fig. 4B), allowing them to regu-
late the extracellular space volume, waste clearance, potassium
buffering, cell migration and calcium signalling (Nagelhus and
Ottersen, 2013), playing an important role in water homeostasis
in the retina, moreover Müller cells play also a role in water
regulation.
3.4. Metabolism
3.4.1. Glucose
The retina exhibits metabolic peculiarities that are related to its
activity. Some speciﬁc characteristics of retinal oxidative and
anabolic metabolism are also found in tissues that manifest highrates of proliferation (for instance, embryonic stem cells and
tumour cells: Ng et al., 2014). Glucose, obtained from external cir-
culation, from internal cellular glycogen stores or from lactate is the
primary metabolite used by retinal cells to produce energy, both in
aerobic and anaerobic conditions (Reichenbach and Bringmann,
2010).
Retinal cells also display specialised metabolic outcomes and
they have adapted to better serve cell house-keeping needs and
speciﬁc demands linked to processing visual inputs (photo-
transduction and neurotransmission). Within the retina, glial cells
and neurons orchestrate complex metabolic relationships
(providing nutrients and metabolites, responding to signals from
neighbouring or distant cells, or adapting the transcriptional ma-
chinery to supply the required metabolites) that ﬁne tune their
metabolic activity to their needs. For example, Müller cells resist
hypoxia and low glucose environments by activating anaerobic
glycolysis and by oxidizing alternative substrates, such as lactate,
glutamate or glutamine in order to obtain energy in the form of ATP
(Kitano et al., 1996; Reichenbach and Bringmann, 2010; Stone et al.,
1999; Winkler et al., 2000). Compared with other tissues, the retina
consumes more ATP (Hurley et al., 2014) and it undergoes an
elevated proportion of aerobic glycolysis, the so-called Warburg
effect (glucose is preferentially converted into lactate, instead of
carbon dioxide andwater by oxidative phosphorylation, despite the
presence of oxygen). The Warburg effect favours rapid ATP pro-
duction when glucose is converted into pyruvate and then fer-
mented into lactate to regenerate oxidized NAD (nicotine adenine
dinucleotide), and it may procure the energy needed for continuous
rhodopsin production or for other processes (Casson et al., 2013; Ng
et al., 2014).
A few examples conﬁrm that retinal cells conﬁgure a metabolic
dialogue based on the expression and distribution of enzymes and
metabolic carriers. Retinal cells also exhibit different energy
metabolic proﬁles (for instance, glia, RGCs, photoreceptors) and a
single cell may have different energy demands in different com-
partments (as is the case for RGCs) while still maintaining the in-
ternal homeostasis (Yu et al., 2013). Glucose and lactate are not the
only primary metabolites catabolised to attend to the energy and
vegetative requirements of the retina. Retinal pigment epithelium
(RPE) cells metabolise fatty acids from phagocytised photoreceptor
outer segment membranes by beoxidation. Also, RPE cells produce
b-hydroxybutyrate from fatty acids (a ketone body) that is further
incorporated into the TCA (tricarboxylic acid cycle) by retinal cells
to obtain ATP, amino acids or other metabolites (due to the
amphibolic properties of TCA). Müller and microglial cells also
establish important metabolic relationships, both in functional and
diseased retinas. In physiological conditions, Müller cells release
ATP to the extracellular space that is used by microglia to fuel their
motility (Wang and Wong, 2014). Accordingly, an effective oxida-
tive and biosynthetic dialogue is established between retinal cell
components (Adijanto et al., 2014).
Among the well-deﬁned house-keeping activities of astrocytes,
they provide neurons with essential metabolites (e.g., glucose), and
they take up Kþ and neurotransmitters from the extracellular space.
Although it was suggested that astrocytes can convert glycogen to
glucose, it is not known under what conditions this occurs in vivo.
Although glucose production via the G6Pase complex in the
endoplasmic reticulum is theoretically possible, other fates of G6P
in the cell include lactate-energy production via glycolysis and
entry into the pentose phosphate pathway. Also, there is contro-
versial evidence that confers a glucose export capacity on astro-
cytes per se. The metabolic relationship between different retinal
cell populations includes many molecules and reactions (Fig. 8),
and their detailed description is beyond the scope of this work. The
reader is referred to some recentworks that deal with thismatter in
Fig. 8. Diagram summarizing the main interactions of glial cells with neurons. Scheme showing glucose metabolism, Kþ homeostasis, H2O, glutamate (Glu) to glutamine (Gln)
metabolism, the secretion of trophic factors and interleukins: A (astrocytes, in green), B (bipolar cells), G (ganglion cells), M (Müller cells, in blue), Mi (microglia, in red), Ph
(photoreceptors).
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et al., 2014; Reichenbach and Bringmann, 2010; Sanderson et al.,
2014; Yu et al., 2013).3.4.2. Lipid metabolism
Anabolic activities in photoreceptors are primarily directed to-
ward the synthesis of outer segment discs, a highly membranous
compartment of the photoreceptor and the site of the photo-
transduction cascade. The retina has the capacity to both synthesize
cholesterol de novo and to take up lipids from the blood (Fliesler
and Keller, 1997). Circulating low-density lipoproteins (LDL) enter
the retina via LDL receptors on RPE and Müller cells (Tserentsoodol
et al., 2006). There is a lipid shuttle from Müller cells to neurons to
meet the need of neurons for lipids, especially to maintain the long
RGC axons and the photoreceptor outer segments, as well as for
synapse formation (Mauch et al., 2001). Müller cells and astrocytes
synthesize ApoE and ApoJ which are assembled into cholesterol-
rich lipoprotein particles that are thought to be secreted into the
vitreous humour. From there the particles may be taken up by RGCs
and transported centrally within the optic nerve. Although the
exact mechanism involved in this uptake is still unclear
(Amaratunga et al., 1996), the implication of Müller glia in the
intraretinal transport of lipids dependent on high density
lipoprotein-like particles has been proposed (Tserentsoodol et al.,
2006).
Docosahexaenoic acid (DHA) is a trophic factor required by
photoreceptors for their disk membranes, and it drives several ac-
tivities in the retina that can help protect photoreceptor cells fromregular exposure to photooxidative damage. As a precursor for the
neuroprotectin, NPD1, DHA helps to upregulate anti-apoptotic
genes of the Bcl-2 family, while downregulating pro-apoptotic
and pro-inﬂammatory genes (Bazan, 2007). Müller cells take up
DHA (Gordon and Bazan, 1990), incorporate it into glial phospho-
lipids and channel it towards the photoreceptors (Politi et al., 2001).
Müller cells also express fatty acid-binding and -transfer proteins
for the transport of DHA and other fatty acids (Deguchi et al., 1992;
Kingma et al., 1998). A potential mechanism for the anti-
inﬂammatory effects of DHA in diabetic retinopathy was recently
suggested, whereby microglia recruit receptors into lipid rafts
(Wang et al., 2015).3.5. Extracellular matrix generators
The extracellular matrix (ECM) provided by macroglia is an
important source of supporting and signalling factors in the retina
and it contributes to the ILM, which is the boundary between the
retinal layers and the vitreous humour. ECM components are key
mediators of glial activation, and they have the capacity to evoke
both regenerative and degenerative effects on RGCs. The ECM
produced by glia is altered during reactive gliosis, with many
studies reporting a dramatic increase in the production of ECM
components and the re-expression of extracellular glycoproteins
that are down regulated after development. The following ECM
components have been identiﬁed in the healthy adult mammalian
retina, unless otherwise speciﬁed.
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Laminins are a family of glycoproteins that are a major con-
stituent of the ILM (Kohno et al., 1987), and the speciﬁc laminin
chains expressed in the retina are now starting to be elucidated.
Laminin acts to anchor cells to the ECM but it also has important
signalling functions transduced via transmembrane receptors like
integrins and dystroglycan. In the adult human retina, laminin g1
has been detected at the ILM of retinal astrocytes, and laminins a4,
b2 and g3 have been associated with Müller cells in the GC layer.
Other laminin chains present in the ILM that may be produced by
retinal macroglia include laminins a1, a5 and b1. The speciﬁc het-
erotrimeric complexes of these laminins in the retinal ECM have
not been fully determined (Libby et al., 2000). RGCs express laminin
chains a2 and b1 in the adult mouse retina, which suggests that
they contribute to their own survival (Morissette and Carbonetto,
1995; Sarthy and Fu, 1990).
3.5.2. Collagen
Collagen is another glycoprotein produced by glia and a con-
stituent of the retinal ECM Collagen types I and IV was identiﬁed in
the ILM of the human adult retina (Jerdan and Glaser, 1986).
Collagen type II was not found in the ILM but found in small
“packages” in the vitreous humour, closely associating with Müller
cell endfeet perhaps as a result of ECM remodelling (Ponsioen et al.,
2005). Furthermore, immortalised human Müller cells express
collagens Types I-VII, IX and XI (Ponsioen et al., 2008). Collagen-
XVIII was also detected at the ILM of the adult human retina.
Collagen XVIII is a basement membrane heparin sulphate proteo-
glycan (HSPG) that can be cleaved to form endostatin. Endostatin is
a broad spectrum inhibitor of angiogenesis and it may interfere
with the pro-angiogenic action of growth factors like basic FGF
(bFGF/FGF-2) and VEGF. This suggests that the expression of Type
XVIII collagen is related to retinal vascularisation in which astro-
cytes play an important role (Keenan et al., 2012).
3.5.3. Vitronectin
Vitronectin, an extracellular glycoprotein that can bind to many
components of the ECM and to integrins (speciﬁcally integrin
avb5). Vitronectin is expressed in the RGC layer of adult human and
mouse retinas, and it is up-regulated, along with its integrin re-
ceptor, following retinal damage (Anderson et al., 1999;Wang et al.,
2006). While vitronectin is expressed by RGCs, it is not expressed
by astrocytes or Müller cells (Anderson et al., 1999).
3.5.4. Fibronectin
Fibronectin is expressed by retinal astrocytes in neonatal rats
and it plays an important role in angiogenesis (Jiang et al., 1994).
Fibronectin was also shown to be produced by cultured adult
mouse retinal astrocytes (Scheef et al., 2005), although there are
inconsistent reports regarding ﬁbronectin expression in the adult
retina and it remains unclear whether or not it is found in the ILM
of adult retina of different mammalian species (Chen et al., 2009b;
Deeg et al., 2011; Hiscott et al., 1992; Kohno et al., 1987; Ljubimov
et al., 1996). Fibronectin has an important developmental role in
vascularisation (Jiang et al., 1994), yet its function in the adult retina
requires further study.
3.5.5. Tenascin
Tenascins are extracellular matrix glycoproteins with adhesive
and counter-adhesive properties that can bind to a multitude of
associated ECM proteins and cell surface receptors, including
members of the integrin family (speciﬁcally a8b1 a9b1 avb3 and
avb6: Morrison, 2006). Tenascins can be cleaved by matrix metal-
loproteinases (MMPs) and serine proteinases, which alter their
binding capacities. Astrocytes from the adult rat optic nerve thatare unsupportive of RGC neurite outgrowth are reportedly tenascin
negative (although Tenascin C -TN-C- was not assessed), whereas
neonatal astrocytes that do support RGC outgrowth are found to
express tenascin (Bahr et al., 1995). A lack of tenascin expression
has ben proposed to contribute to the failure of adult CNS regen-
eration (Bartsch et al., 1992). More recently, TN-C upregulation was
seen in optic nerve head astrocytes after experimental injury in rats
(Johnson et al., 2007) and in glaucoma patients (Pena et al., 1999).
This suggests that tenascin is downregulated in cultured adult as-
trocytes that perhaps do not reﬂect events in vivo.
Interestingly, TN-C dampens the reactivity of cultured human
astrocytes, transforming them to a quiescent phenotype, and glia
appear to produce their own TN-C to modulate their own reactive
phenotype in an autocrine manner (Holley et al., 2005). Perhaps,
the expression of TN-C during regeneration serves to maintain a
manageable level of reactivity in order to promote a less inhibitory
environment for RGC regeneration. TN-C expressed by astrocytes
also acts at the retinal optic nerve junction, where it serves as a
crucial molecular barrier preventing myelinating oligodendrocyte
precursor cells (OPCs) from entering the retina (Bartsch et al., 1994;
Morcos and Chan-Ling, 2000).
Cultured Müller glia from P3 mice promote RGC axonal
outgrowth and express the large TN-C isoform (Siddiqui et al.,
2009). Indeed, some isoforms of TN-C inhibit neurite extension
whereas others vigorously promote neurite outgrowth, depending
on their FnIII domains. The FNIII Domain D of TN-C is necessary to
stimulate retinal outgrowth on Müller glia cells (Siddiqui et al.,
2008). An increase in Müller cell proliferation has been observed
on stiff substrates and an upregulation of connective tissue growth
factor (CTGF) and TN-C on softer substrates (Davis et al., 2012).
Recently, Müller cells were shown to have the potential to re-enter
the cell cycle and differentiate into multipotent neuronal pro-
genitors that can regenerate cells in damaged areas. This can be
induced in vitro by exposure to FGF2. TN-C is important in this
process as it enhances Müller cell sensitivity to FGF2. Moreover, de-
differentiation was found to be impaired in TN-C knock-out mice
(Besser et al., 2012).
3.5.6. Proteoglycans
Chondroitin Sulphate Proteoglycans (CSPGs) are produced by
retinal glia and have both positive and negative effects on RGCs.
CSPGs are crucial mediators of axonal pathﬁnding during devel-
opment, yet they are known to be inhibitory to axonal regeneration
(Carulli et al., 2005). The CSPG, neurocan, is upregulated by Müller
cells in adult rat retina during reactive gliosis, suggesting that these
cells may not support RGC regeneration (Inatani et al., 2000). A
comparative study of the ECM produced by different glial cells
found that the ECM of Müller cells from neonatal mice express low
levels of CSPGs and high levels of growth promoting molecules like
laminin, ﬁbronectin and TN-C. These Müller cells are a favourable
substrate for RGC axon outgrowth and when the production of
CSPGs is inhibited, axonal growth is enhanced. This suggests that
the ECM of neonatal Müller cells contains more stimulating than
inhibitory components and that it is a favourable substrate for RGC
axons (Siddiqui et al., 2009). These results highlight the need to
further analyse the ECM produced by adult retinal glia in order to
assess which growth promoting and growth inhibiting factors are
altered with respect to neonatal cells.
Heparan Sulphate Proteoglycans The ILM of the adult human
retina contains diverse heparan sulphate proteoglycans (HSPGs)
including perlecan, agrin and Collagen Type XVIII (Clark et al., 2011;
Keenan et al., 2012). HSPGs are crucial for axonal guidance during
retinal development (Chai and Morris, 1999), although their role in
the adult retina is not well understood. In mature tissue, sulphated
proteoglycans are crucial for the correct function of many signal
E. Vecino et al. / Progress in Retinal and Eye Research 51 (2016) 1e4016transduction pathways and for the binding of a multitude of mol-
ecules, including growth factors (e.g., VEGFs and FGFs), growth
factor receptors, chemokines, matrix molecules, proteases and
enzyme inhibitors. For this reason, it would be interesting to
explore the roles of HSPGs in relation to mature RGCs since there
may be multiple signalling pathways that are dependent upon this
type of regulation.
3.5.7. Intermediate Filaments (IFs)
Following CNS injury, astrocytes andMüller cells upregulate the IF
proteins GFAP, vimentin and nestin, which alters their physical
properties and makes the cells more rigid. This allows them to
establish a glial scar that is a physical and biochemical barrier to
infection, as well as a barrier to regeneration. The upregulation of IFs
also increases contactbetweencytoskeletal components and theECM,
enabling the cells to initiate rapid cytoskeletal alterations. Astrocytes
andMüller cells have a polarisedmorphology (Enger et al., 2012) and
the loss of this polarity may be one factor that contributes to their
reactivity as they lose the crucial connection with the ECM.
In the retina, astrocytes and Müller cells express GFAP and
vimentin at detectable levels in normal adult tissue and both are
dramatically upregulated following damage to the retina (Lewis
and Fisher, 2003). It is unclear if GFAP is expressed by unreactive
Müller cells since while there are reports that it is only expressed at
times of stress (Kim et al., 1998; Xu et al., 2009) it has also been
detected in Müller cell processes of healthy retinas (Erickson et al.,
1987). Increased expression of GFAP and vimentin increases the
stiffness of the cells, which does not encourage axonal regeneration
because growing neurites prefer soft substrates (Bringmann and
Wiedemann, 2012). There is also evidence that retinal astrocytes
in zebraﬁsh express GFAP weakly and rather, they rely on cyto-
keratin IFs to maintain their structural stability, which perhaps
produces a less rigid scar than in mammals (Koke et al., 2010).
There may also be alterations to intrinsic cell receptors in adult
RGCs that make them unresponsive to extracellular guidance cues
since they are less capable of extending processes through 3-
dimensional cultures of astrocytes than embryonic RGCs, suggest-
ing that their cellecell adhesion properties are signiﬁcantly altered
(Fawcett et al., 1989).
Nestin is expressed very weakly in healthy tissues but it is
upregulated after retinal damage, for example in induced glaucoma
(Xue et al., 2006a), optic nerve transection (Xue et al., 2006b) or
after laser injury (Kohno et al., 2006). Nestin was recently shown to
be upregulated in a subpopulation of Müller/astrocytes in the RGC
layer in a rat model of Retinitis pigmentosa. Nestin is better known
as a stem cell marker and it is associated with proliferating cells,
such as stem cells and progenitor cells, and it was proposed that the
re-expression of nestin signiﬁes the dedifferentiation of Müller
cells (Valamanesh et al., 2013). The upregulation of nestin byMüller
cells and astrocytes has also been reported following experimental
retinal detachment in the adult rat and where differential expres-
sion of nestinwithin the Müller cell populationwas observed (Luna
et al., 2010). Synemin is another IF protein that is upregulated in
both Müller glia and astrocytes and like nestin, it is similarly
downregulated after development and its re-expression in Müller
cells following injury may be an indicator of de-differentiation
(Luna et al., 2010).
In summary, the ECM substrate provided by conﬂuent Müller
cells in vitro favours the growth and regeneration of RGCs (Garcia
et al., 2002). Moreover, the best conditions for RGCs involve a
combination of ECM plus secreted factors fromMüller cells (Vecino
et al., 2015b).
3.5.8. N-Cadherin
N-Cadherin is essential for neurite outgrowth, as evident whenembryonic chick RGCs are cultured on rat cortical astrocytes
(Neugebauer et al., 1988). Similarly, N-Cadherin is required for
neurite outgrowth when in contact with Müller cells in vitro and
in vivo (Riehl et al., 1996). Retinal axons from embryonic mouse
explants express N-cadherin when cultured on astrocytes whilst
those from adult explants do not.
N-Cadherin fulﬁls crucial developmental functions in the em-
bryonic retina and it is downregulated in the adult retina (Bates
et al., 1999). However, N-Cadherin is upregulated during regener-
ation in the adult zebraﬁsh retina (Liu et al., 2002). Thus, the
inability of the mammalian retina to re-express N-Cadherin
following injury may be one of the reasons that RGCs don't
regenerate, making N-Cadherin a potential therapeutic target.
3.5.9. Integrins
Integrins are membrane-spanning adhesionmolecules that link
the intracellular cytoskeleton to the ECM. Integrins are composed
of a and b subunits, of which there are multiple types, and the
resulting heterodimers allow cells to respond to adhesion through a
number of different ECM ligands. Integrin-mediated cell-adhesion
allows cells to communicate with their environment and the sur-
rounding ECM, favouring alterations to the extracellular milieu to
be relayed back to the cell, which then alters its morphology
accordingly. Loss of the connection between the cell and the ECM,
for example by MMP induced proteolysis, is one way in which
retinal degeneration can progress. Based on current evidence,
integrin signalling in RGC-glia interactions is crucial for cell sur-
vival, process extension and the maintenance of correct retinal
function, although the promiscuity of integrin subunit hetero-
dimers combined with their temporal expression in the retina
make it difﬁcult to draw deﬁnitive conclusions regarding the
functions of speciﬁc integrins. What is clear is that throughout
retinal development and during degeneration there is a strong
requirement for b1 integrin signalling to promote cell survival and
outgrowth. The importance of b1 class integrins in mediating RGC
neurite outgrowth in the developing retina has been well charac-
terised in the chick andmouse embryonic retina and the a-subunits
were found to be expressed in RGCs (Bosco et al., 1994; Bossy et al.,
1991; Bradshaw et al., 1995; Cann et al., 1996; Cohen et al., 1987; de
Curtis, 1993; Duband et al., 1992; Hall et al., 1987; Sheppard et al.,
1994).
Adult rat RGCs preserve the capacity to survive and regenerate
in the presence of different ECM components, such as laminin,
ﬁbronectin, collagen I and collagen IV, demonstrating the tremen-
dous plasticity of adult RGCs to reprogram their ability to express
different integrins depending of the substratum inwhich they grow
(Vecino et al., 2015b). It is clear that RGCs are in contact with
different ECM components produced by different glial cells within
the retina. As the axons exit the optic nerve they come into contact
with the ECM components of the optic nerve head, lamina cribosa,
optic nerve axons and oligodendrocytes. Thus, RGCs must express
different sets of integrins in order to survive when in contact with
different substrata and glial cell types, preserving their capacity to
regenerate. We have described the beneﬁcial effect of Müller cells
on the survival and the capacity of RGCs to regenerate neurites
(Fig. 9). Müller cells secrete beneﬁcial factors but they are even
more beneﬁcial when RGCs are grown on a conﬂuent Müller cell
substratum (Garcia et al., 2002; Higginson et al., 2013). The bene-
ﬁcial effects of Müller cells therefore appear to be due to secreted
factors and adhesion molecules present on these cells.
Adult human Müller cells express a1, a2, a3 and b1 integrin
subunits in culture (Guidry et al., 2003) and cultured rat Müller
cells from P3 rats strongly express the b1 integrin subunit (Siddiqui
et al., 2009). Multiple integrin heterodimers are expressed in as-
trocytes and the expression of a2, a3, a6, b1 and b4 integrin
Fig. 9. Effect of Müller cells on RGCs in vitro. (A) Rat RGCs cultured on conﬂuent pig retinal Müller cells monolayer. (B) RGCs incubated directly on the laminin-poly-lysine substrate.
RGCs were labelled with antibodies against-bIII Tubulin (green) and the nuclei were stained with DAPI (blue). Note that there are more RGCs when grown on Müller cells, and with
longer neurites. Scale bar ¼ 50 mm.
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been reported (Morrison, 2006). Thus, based on the resultant het-
erodimers, we can predict that laminin and collagen are important
ECM components in this structure. In terms of RGC-astrocyte in-
teractions, whilst there could be bi-directional integrin communi-
cation in both cells, the primary role of astrocytes in this context is
likely to be the provision of binding partners for the integrin sub-
units expressed by RGCs in order to relay survival signals.
3.6. Regulation of neuronal activity
Glial cells are classically viewed as passive participants in syn-
aptic function. However, there is much evidence that there is a
dynamic two-way communication between glia and neurons at the
synapse (Barres, 1991). Neurotransmitters released from pre-
synaptic neurons evoke increases in Ca2þ in adjacent glia. Acti-
vated glia then release transmitters, including glutamate and ATP,
and these glio-transmitters feedback onto the pre-synaptic termi-
nal to either enhance or supress further neurotransmitter release.
Transmitters released from glia can also directly stimulate post-
synaptic neurons, producing either excitatory or inhibitory re-
sponses. Müller cells envelop synapses in the retina, like Bergmann
glia in the cerebellum or Schwann cells at the pre-synaptic
neuromuscular junction. Thus, the precise shaping of synaptic ac-
tivity depends upon the kinetics of both the pre-synaptic neuro-
transmitter release and transmitter re-uptake. In the retina,
photoreceptor cells, neurons and macroglial cells express high-
afﬁnity transporters for neurotransmitters, all contributing to
synaptic function in the retina.
As previously indicated in this review the role of microglia is
mainly related to their macrophage action during damage and to
their capacity of secreting chemical signals that contribute to
inﬂammation, cell death and cell survival. However, microglia also
have essential activities that control synaptic connections and
synaptic activity in the healthy brain, both during development and
in adulthood (Schafer et al., 2013). Microglia contact synaptic ele-
ments, dendritic spines and peri-synaptic astrocytes, through
processes that extend and retract dynamically (Tremblay et al.,
2010). The release of microglial factors inﬂuences both neuro-
transmission and synaptic plasticity (Bilimoria and Stevens, 2014;
Schafer et al., 2013). Microglia modify the number of synapses in
different circumstances and they directly eliminate speciﬁc syn-
aptic contacts or those in close collaboration with astrocytes
(Miyamoto et al., 2013). One key candidate that seems to play an
important role in synapse elimination/remodelling is the classical
complement cascade (Mastellos, 2014; Stephan et al., 2012; Stevens
et al., 2007). For instance, the remodelling of synapses during thedevelopment of the visual system depends on the integrity of the
complement cascade, given that genetic deletion of important
components of this protein family block the capacity of microglia to
properly remove speciﬁc synapses (Schafer et al., 2012). Indeed,
astrocytes induce the expression of complement elements in the
CNS and they act in conjunction with microglia that eliminate
complement tagged synapses during synapse pruning (Stephan
et al., 2012). Astrocytes also engulf and eliminate synapses
through a mechanism independent of complement activation, both
during development and in adults (Chung et al., 2013). Other mo-
lecular mechanisms that trigger the phagocytotic intervention of
microglia involve the major histocompatibility complex (MHC class
1), glutamate receptors and ATP signalling, etc (Miyamoto et al.,
2013).
3.6.1. Gamma-Aminobutyric acid (GABA)
In addition to GABA and Glutamate, Müller cells express, take up
and exchange various neurotransmitters (Bringmann et al., 2013).
In the outer retina, Müller cells are responsible for all GABA
removal, whereas they share that task with amacrine cells in the
inner retina (Marc, 1992). Astrocytes express a wide variety of
neurotransmitter receptors (Porter and McCarthy, 1997) and glia
responses to neurotransmitters were initially characterized using
cultured astrocytes as a model system. The release of several
different neurotransmitters from active neurons can stimulate glia
in intact tissue preparations, evoking increases in glia calcium.
These responses are mediated by several glutamate receptors,
GABAB receptors and muscarinic ACh receptors (Kang et al., 1998;
Pasti et al., 1997). Moreover, the capacity of glia to respond to
neuronal activity suggests that theymight regulate local blood ﬂow
in response to changes in neuronal activity (Paulson and Newman,
1987), which would be crucial for retinal damage.
Transmitter release from neurons can stimulate glia and pro-
voke the release of glutamate, ATP and other neuroactive sub-
stances from glia. These gliotransmitters that are released by glia
can directly stimulate post-synaptic neurons, evoking either
excitatory or inhibitory responses in these cells (Newman, 2003).
However, whether such responses also take place in vivo remains
unclear. Another interesting question that must be addressed is if
the heterogeneity of glial cells and their actions inﬂuence the sur-
vival of different neurons, or if different neurons are responsible for
modulating resistance to damage.
3.6.2. Glutamate
Glutamate is the main excitatory neurotransmitter in the retina,
which is used in the transmission of visual signals by photorecep-
tors, bipolar and ganglion cells. In the outer retina, glutamate is
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this release is inhibited by light. In the IPL, ON-bipolar cells release
glutamate during light exposure whereas OFF-bipolar cells release
glutamate in the dark (Bringmann et al., 2013). Müller cells are the
main elements responsible for the removal of excess glutamate
released by the RGCs. The Müller cells are interposed between the
vessels and RGCs, creating a barrier through which the Müller cells
provide nutrients and release essential substances to the RGCs
(Bringmann et al., 2009b). The major glutamate uptake carrier of
Müller cells is the electrogenic glutamate-aspartate transporter
(GLAST, excitatory amino acid transporter-1, EAAT1: Derouiche and
Rauen, 1995).
After EAAT-mediated glutamate uptake into Müller cells, gluta-
mate is converted to glutamine by glutamine synthetase (GS), and
subsequently, glutamine is transported back to the neurons for
glutamate re-synthesis (Danbolt, 2001). Glucose deprivation results
in an increased glutamate uptake as well as the upregulation of
EAAT1 and EAAT2 expression, indicative of a regulatory mechanism
that prevents excitotoxicity in neighbouring RGCs. Indeed, glutamate
uptake by Müller cells would appear to be essential to RGC survival
(Toft-Kehler et al., 2014). The transport process itself triggers a signal
transduction cascade that involves the activation of p60src, PI3K and
PKB (Akt) linked to extracellular Ca2þ entry, which not only promotes
translation by Ser-2448 phosphorylated mTOR but also, transcrip-
tional activity mediated by Ca2þ-dependent binding of inducible
transcription factors, such as AP-1. These results further support the
pivotal role of glia cells in glutamatergic transmission in the retina
(Lopez-Colome et al., 2012). Signiﬁcantly, various receptor agonists,
including VEGF, erythropoietin and neuropeptide Y can induce the
release of glutamate from Müller cells, which induces ATP release
upon activation of mGluRs (Bruckner et al., 2012).
3.6.3. ATP and adenosine
Glutamate and ATP are candidates for neuron-to-glia signalling
associated with volume (Uckermann et al., 2006). Indeed, ‘patho-
logical’ osmotic swelling of retinal (Müller) glia in rat retinal slices
(evoked by the potassium channel blocker, barium chloride, by
inﬂammatory lipid mediators, or under pathological conditions like
diabetes and ischemia) can be prevented by pharmacological acti-
vation of purinergic P2Y and adenosine receptors (Uckermann
et al., 2006; Wurm et al., 2008a). Activation of purinergic re-
ceptors was recently concluded to be fundamentally involved in the
regulation of glial cell volume and thus, in the homeostasis of the of
the extracellular space mediated by these cells (Wurm et al., 2011).
Moreover, the inhibitory effects of VEGF and glutamate on the
swelling of mouse Müller cells is mediated by transactivation of
P2Y1R, as well as by intracellular calcium signalling through IP3R2
activation (Grosche et al., 2013).
Adenosine is a reactive metabolite involved in cellular
communication in some pathological states and in the eye, retinal
ischemia and/or hypoxia provokes an increase of adenosine. Four
adenosine receptor subtypes have been identiﬁed (A1, A2A, A2B
and A3: Kang et al., 2013). In the retina, adenosine suppresses
excitatory neurotransmission through various mechanisms,
including the inhibition of pre-synaptic voltage-dependent calcium
channels (Housley et al., 2009). Since adenosine is a downstream
mediator of the swelling-inhibitory actions of glutamate and ATP, it
is likely that the inhibitory effect of adenosine induces chloride
channel opening (Bruckner et al., 2012).
3.7. Synaptic pruning
Synaptic pruning refers to the sculpting that reduces and re-
models excess synaptic neuronal contacts to obtain functional
neuronal circuits, a process that takes place mainly duringdevelopment but that also occurs in the mature brain. Astrocytes
and microglia fulﬁl a key function in synaptic pruning through
different mechanisms that ultimately combine to conform a robust
neural network. Microglia employ their phagocytotic and secretory
activities to control the neural circuits in healthy brains (Bilimoria
and Stevens, 2014) In mouse, for example, microglia engulf syn-
apses during synaptic maturation given that proteins like PSD95 (a
marker of excitatory postsynaptic density) and SNAP25 (a pre-
synaptically localized protein) can be found inside microglial cells
(Paolicelli et al., 2011). Synaptic pruning is delayed in mice with
microglia lacking the chemokine receptor Cx3cr1, indicating that
their neuronal networks were immature (Paolicelli et al., 2011).
Astrocytes in both the adult and developing brain mediate the
elimination of synapses and therefore, they participate in the
reshaping of neural circuits. Astrocytes participate in the formation
of functional synapses within the CNS and they can control synapse
maintenance in vitro (Ullian et al., 2001). Glypican (HSPGs) 4 (Gpc4)
and 6 (Gpc6) are secreted by astrocytes, and they induce functional
synapses between puriﬁed RGCs (Allen et al., 2012) Indeed, the
application of Gpc4 to neurons increases glutamatergic neuro-
transmission. Astrocytes can also eliminate synapses through two
phagocytotic receptors, namely Megf10 and Mertk, and their ca-
pacity to engulf synapses depends on neuronal activity (Chung
et al., 2013).
The complement system is part of humoural immunity,
involving a group of proteins that participate in the elimination of
alien cells and debris. However, new functions of this tagging sys-
tem are observed in relation to neuronal differentiation and the
establishment of neuronal networks in the CNS (Mastellos, 2014).
Synaptic components tagged with proteins of the complement
system are eliminated by microglia and astrocytes, and they
collaborate in this process by secreting signals that induce the
synthesis of complement proteins by neurons (Stephan et al., 2012).
Selective elimination of synapses during post-natal development
requires the expression of C1q in cultured RGCs, the initiating
protein in the complement cascade (Stevens, 2008; Stevens et al.,
2007). Moreover, the absence of the C1q or C3 protein in mice
(downstream elements in the complement cascade) leads to
excessive retinal innervation of the LGN (lateral geniculate nucleus)
as a consequence of defective synapse pruning, and neural activity
regulates the engulﬁng capacity of microglia (Schafer et al., 2012).
Other phagocytotic mechanisms may be implicated in the process
of synaptic pruning and thus, further studies in other regions of the
CNS and in different experimental models will be needed to
ascertain the precise role of microglia and astrocytes in the
remodelling of synapses during development and in maturity.
Indeed, many questions are still unanswered and the role of glial
cells in CNS remodelling remains ill-deﬁned (Schafer et al., 2013).
A close relationship exists between Müller cells and RGCs,
whereby glial cell processes often ensheath ganglion cell somata, as
well as some of the axonal, dendritic and synaptic regions of these
retinal neurons, an ensheathing pattern also common to astrocytic
processes (Hollander et al., 1991). This intimate association be-
tween glia and neurons is thought to allow glial cells to promote
synapse formation and it helps maintain neuronal function by
providing nerve terminals with energy substrates and neuro-
transmitter precursors (Pfrieger and Barres, 1996).
3.8. Immune responses
The retina is considered an immune-privileged tissue and
therefore, a multitude of mechanisms operate in the eye to limit the
harmful inﬂammation that foreign substances provoke. At the same
time, different mechanisms defend the eye from invading patho-
gens, with ocular cell surface and soluble factors maintaining the
E. Vecino et al. / Progress in Retinal and Eye Research 51 (2016) 1e40 19eye's immunosuppressive nature. RGCs are thought to play a major
role in the recognition and subsequent clearance of pathogens
during infection, and they are believed to represent the ﬁrst line of
defence in the retina. While microglial cells are mainly responsible
for these effects, astrocytes and Müller cells also collaborate in this
activity. Microglial cells are capable of modifying their positions in
order to maintain homeostasis, however, both astrocytes and
Müller cells can detect damage since both expand their projections
to the blood vessels while essentially maintaining their positions.
Different immune cells are situated at different locations within
the retina. Dendritic cells (MHC-IIþ33D1þ) are preferentially
located around the optic disc and the peripheral margin of the
retina (Xu et al., 2007). Moreover, their role in optic nerve and
retinal inﬂammation remains to be elucidated. Perivascular mac-
rophages play a critical role in retinal vascular inﬂammation and
they may also participate in neuronal retinal defence. Microglial
cells are the main innate immune cells in the retina and their
activation is tightly regulated by a number of inhibitory pathways,
including CD200/CD200R (Copland et al., 2010) or CX3CL1/CX3CR1
(Chen et al., 2012). Complement proteins are expressed in the
retina under normal physiological conditions (Luo et al., 2011) and
their expression augments in pathological conditions like inﬂam-
mation (Chen et al., 2010) and ageing (Chen et al., 2007). Comple-
ment activation is related to various retinal inﬂammatory and
degenerative diseases, and modulating these pathways may have
therapeutic applications.
Recent studies have shown that Müller glia actively participate
in retinal innate immunity, speciﬁcally in infectious conditions like
bacterial endophthalmitis, an activity that involves their Toll-like
receptors, phagocytosis, and the secretion of cytokines and che-
mokines. Müller cells also inﬂuence the adaptive arm of immunity
by inhibiting the proliferation of T-cells via membrane-bound
molecules. As a consequence of Müller cell activation, pro-
inﬂammatory cytokines and other potent mediators of inﬂamma-
tion are synthesised and released (Kumar et al., 2013).
Müller glia cells increase complement protein expression
(Kuehn et al., 2006). The complement protein C1q, an initiator of
the classical complement cascade, is upregulated in neurodegen-
erative diseases like Alzheimer's and amyotrophic lateral sclerosis
(ALS), as well as in rodent and human glaucoma (Stasi et al., 2006;
Stevens et al., 2007). The complement cascade has been implicated
in the normal elimination of synapses by RGCs during visual system
development in the DBA/2J mouse model of glaucoma (Howell
et al., 2007). Thus, it might be possible that complement protein
deposition occurs prior to signiﬁcant loss of RGCs in the IPL. These
ﬁndings strongly suggest that a normal mechanism of develop-
mental synapse elimination is reactivated in the mature visual
system by the glaucomatous process, and that this process of syn-
apse elimination may well entirely drive glaucomatous neuro-
degeneration. Most of the secreted C1q is released by microglia,
which express C1q mRNA strongly. However, what communication
occurs between astrocytes andmicroglia, and the chronology of the
events that take place in the early stages of glaucoma remain un-
clear, although it is known that microglial activation is an early
event in this process (Bosco et al., 2008; Steele et al., 2006).
Müller cells produce different cytokines in response to different
stimuli. For example, IL-1b (interleukin-1b) and TNF-a are potent
inducers of IL-8 expression in Müller cells (Liu et al., 2014b), and IL-
1b and lipopolysaccharide (LPS) also provoke IL-6 production
(Yoshida et al., 2001). IL-6 is a key cytokine in the host's defence
against environmental stress, such as infection, inﬂammation and
injury (Mesquida et al., 2014). Indeed, the dysregulated and
persistent production of IL-6 has been implicated in the develop-
ment of various autoimmune and chronic inﬂammatory diseases,
as well as ocular disorders. These cytokines can stimulateﬁbroblasts, endothelial cells and macrophages to produce chemo-
kines, promoting the recruitment of neutrophils and macrophages
to the retina, thereby resulting in further tissue damage and chronic
inﬂammation. It is now known how IL-6 expression is regulated in
Müller cells. These cells produce high levels of IL-6 in response to
IL-1b stimulation and activation of the p38MAPK/NF-kB signalling
pathway plays a predominant role in regulating IL-6 expression (Liu
et al., 2014c).
Some activities are common to the immune system and CNS: the
secretion of immunoregulatory cytokines; the response to cyto-
kines; and antigen presentation. These properties reﬂect the
physical contact between the two systems (microglia, astrocytes
and Müller cells presenting antigen to T cells) and their commu-
nication via soluble factors like cytokines. Indeed, cytokines
mediate a complex circuit of interactions, especially in the event of
lymphoid-mononuclear cell inﬁltration into the retina. The secre-
tion of interferon g (IFN-g) by inﬁltrating activated T cells could
initially induce astrocytes, Müller cells and microglia to express
class I and class II MHC antigens, as well as priming these cells for
subsequent cytokine production that would contribute to either the
initiation and/or propagation of immune responses. Müller cell-
mediated inhibition of T cell proliferation can be overcome by
treating Müller cells with glucocorticoids, presumably preventing
the expression of the Müller cell inhibitory factor (Roberge et al.,
1991), supporting a role for Müller cells as antigen-presenting
cells (APCs) in the retina. A number of inﬂammatory mediators in
the CNS act by ultimately suppressing immune responses, inhibit-
ing class I and II MHC expression, and dampening cytokine pro-
duction by glial cells, such as that of prostaglandins, IFN-a and IFN-
b, TGFb and neurotransmitter like norepinephrine. The induction
and ultimate downregulation of immune responses and cytokine
production within the retina depends on: a dynamic interaction
between a variety of peripheral immune cells and retinal cells; the
activation of these cells; the presence of cytokines with pleiotropic
effects; the concentration and location of these cytokines in the
retina; and the temporal sequence in which a particular cell re-
sponds to these cytokines. Thus, the ultimate outcome of immu-
nological and inﬂammatory events in the retina will be determined
in part by the interplay of these parameters (Benveniste, 1993).
3.9. Gliosis
In the retina, reactive gliosis alters the morphology of the retina
through hypertrophy, Müller cells and astrocytes provoking the
thickening and enlargement of processes. This response occurs in a
multitude of disorders like trauma, ischemic damage, infection,
neuroinﬂammation or neurodegeneration, and in addition to the
morphological changes, dramatic alterations in astrocyte gene
expression occurs (Hernandez et al., 2000; Pekny and Nilsson,
2005). The concept of reactive astrogliosis, especially its molecu-
lar and cellular characteristics, are still ill-deﬁned, and we are only
starting to understand its multifaceted contribution to disease
pathogenesis and recovery from injuries (Barres, 2008; Burda and
Sofroniew, 2014; Zamanian et al., 2012). In reactive gliosis the
expression of many genes is altered, and these cells exhibit distinct
morphological and functional features. Given the molecular
complexity of the response of reactive astrocytes, it is unlikely that
a single molecular target or pathway will be implicated, indicating
that gliosis is a very complex reaction in which many elements are
implicated (Pekny and Pekna, 2014).
In response to infection and in certain inﬂammatory scenarios,
Müller cells undergo reactive gliosis. Müller gliosis is a generalized,
more unspeciﬁc, yet a very complex response ofMüller glia towards
injury or infection. Müller cells become activated by nearly every
pathological challenge in the retina (Bringmann et al., 2009a).
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the injured or diseased tissue that sets off a molecular cascade
within the glial cells to provoke a change of state (Fischer and
Bongini, 2010). Typical features of Müller cell gliosis involve
cellular hypertrophy, up-regulation of IF expression (e.g., GFAP and
vimentin), increased rates of proliferation, loss of function,
inﬂammation, downregulation of GS expression, and tissue and
vasculature remodelling (Belecky-Adams et al., 2013).
A mild to severe continuum of the states of reactive gliosis may
exist. In the mild to moderate forms of gliosis, the cells may un-
dergo hypertrophy and show some changes to their functionality,
yet if the trigger is removed, the cells might revert back to their
former condition without altering the tissue. In the more severe
forms of reactive gliosis, cells undergo hypertrophy, lose their
functionality, form glial scars that are inhibitory to axonal regen-
eration and neuronal survival, and they may also proliferate The
more severe state is marked by the persistence of these charac-
teristics. Proliferative gliosis is generally associated with chronic
gliosis and it is usually detrimental but it can also have a beneﬁcial
effect (Sofroniew, 2009). In such a state, the integrity of the
blooderetina barrier is lost and as a result, serum components leak
into the perivascular space, causing the re-entry of Müller cells into
the cell cycle and their proliferation (Bringmann et al., 2009a;
Coorey et al., 2012).
The release of VEGF byMüller cells under conditions stimulating
gliosis is especially interesting, as it acts in two directions. VEGF is
neuroprotective at low concentrations but at high concentrations it
causes all sorts of vascular pathologies. VEGF has neurotrophic ef-
fects (Zheng et al., 2012) and can prolong the survival time of cells
by inducing angiogenesis, which in turn attenuates brain edema
after cerebral ischemia/reperfusion and neuron injury. The neuro-
protective effect of VEGF was proposed to be unrelated to its
angiogenic effect but more closely related with its direct stimula-
tion of neuronal and endothelial activity (Oosthuyse et al., 2001).
The regeneration of neurons together with angiogenesis could be
improved by VEGF, especially after ischemia (Ma et al., 2011).
Conversely, the excessive and prolonged expression of VEGF has
devastating effects on the retinal vasculature and/or Müller cell
proliferation, which in turn might lead to retinal neuro-
degeneration (Tolentino et al., 2002). Moreover, calcium contrib-
utes to the high-glucose-induced expression of the angiogenic
factors HIF-1a and VEGF by retinal Müller cells. The activation of
the CaMKII-CREB pathway by high-glucose may be a possible
mechanism underlying the pathogenesis of diabetic retinopathy (Li
et al., 2012).
Müller cells are not alone in inﬂuencing the effects of VEGF as
astrocytes are also considered a target for ischemic damage. Apart
from their neuroprotective effect on neurons and their detoxiﬁca-
tion of various ROS at the acute stage of ischemic stroke, reactive
astrocytes profoundly affect later post-ischemic stages. This inﬂu-
ence may be mediated by the secretion of VEGF, which stimulates
the formation of new blood vessels and synaptogenesis, or by the
secretion of synaptogenic thrombospondin (Christopherson et al.,
2005). The positive stimulatory effect of VEGF on vessel and syn-
apse formation in ischemic stroke, contrasts with its induction of
blood-retinal barrier breakdown and lymphocyte inﬁltration in
autoimmune CNS inﬂammation (Argaw et al., 2009). It is also
noteworthy that treatment with GDNF enhances neuronal survival
in ischemic brain tissue and that GDNF is up regulated in reactive
astrocytes in the peri-infarct region (Kokaia et al., 1999). Netrin-4, is
a positive regulator of retinal angiogenesis and Müller cells
generate Netrin-4 in a hypoxia- and VEGF-dependent manner,
another example of a multifunctional protein produced by Müller
cells that may inﬂuence their complex relationship with retinal
neurons. Netrin-4 can support both axon guidance andangiogenesis in early development, as well as modifying regener-
ative neurite growth and neovascularisation (NV) under patho-
logical conditions (Lange et al., 2012).
Surfactant protein A (SP-A) upregulates cytokine expression in
lung disease associated to prematurity. SP-A expression and local-
ization has now been characterized in the mouse retina, as has its
impact on NV in the mouse. Retinal and Müller cell SP-A is upre-
gulated via the NFkB pathway and it is up regulated during the
hypoxia phase of oxygen-induced retinopathy (OIR). A lack of SP-A
attenuates NV in the OIR model and thus, SP-A may be a marker of
retinal inﬂammation during NV (Bhatti et al., 2014). Müller cells
also produce PEDF (Pigment epithelium-derived factor), TGF-b and
thrombospondin-1 as anti-angiogenic proteins that are important
in adjusting the ‘‘angiogenic balance’’ (Eichler et al., 2004). Recent
studies suggest that in addition to PEDF (Yafai et al., 2007), TGF-b2
is one of the Müller cell derived factors that limit intra-retinal NV
(Yafai et al., 2014).
Within the mammalian retina, both the Müller glia and retinal
astrocytes react to injury and disease. Although the mechanisms
and triggers involved have not been fully characterized. A variety of
growth factor signalling mechanisms have been found to be
important in reactive gliosis, such as those of EGF, FGF, TNF-a,
ciliary neurotrophic factor (CNTF), insulin and WNTs (Nakazawa
et al., 2006; Sofroniew, 2009). Bone morphogenetic protein 7
(BMP7) also induces changes in the mRNA and protein of markers
typically associated with reactive gliosis in retinal astrocytes and
Müller glial cells, including GFAP, GS, a subset of CSPGs, MMPs, and
other molecules (Dharmarajan et al., 2013).
3.10. Neuroprotection
3.10.1. Neurotrophic factors
Neurotrophins and growth factors are involved in the survival,
differentiation and development of neurons. Administration of
different combinations of neurotrophins in the eye has been re-
ported to increase RGC survival in different experimental para-
digms. Glial cells are important to maintain the survival of neurons,
although the factors involved in the development and survival of
glial cells themselves are less well deﬁned. Glial like Müller cells,
astrocytes and microglia are known to synthesise neurotrophic
factors and these can directly or indirectly mediate neurotrophic
actions (Garcia et al., 2003; Ruiz-Ederra et al., 2003; Vecino et al.,
1998a, 1998b). In order to deﬁne the cell-to-cell communication
between Müller glia and neurons, it is essential to ﬁrst isolate the
respective cell types. When adult retinas were maintained in vitro
for 6 days, the expression of neurotrophins and their receptors was
preserved in glial cells and in RGCs, irrespective of the substrate on
which they were cultured (Fig. 10: Garcia et al., 2002). Moreover,
the factors secreted by Müller cells offered protection to RGCs
(Garcia et al., 2003).
The distribution of neurotrophins and their receptors in the
mammalian retina has been studied in detail, even in pathological
conditions like ischemia or following NMDA induced exitotoxicity
(Vecino et al., 1998b, 1999). BDNF expression by rat RGCs is
completely blocked after intravitreal injection of NMDA, as is
choline acetyltransferase (ChAT) immunoreactivity associated with
a subset of amacrine cells. However, immediately after NMDA in-
jection, BDNF mRNA expression by RGCs and its immunoreactivity
is enhanced, while the amacrine cell ChAT immunoreactivity is
clearly reduced, and expression of the mRNA transcripts encoding
rhodopsin and Thy-1 does not change. However, a few hours later
an increase in BDNF expression is no longer apparent, suggesting
that the synthesis of BDNF increases in RGCs immediately after an
NMDA insult a natural protective mechanism in retinal cells
(Vecino et al., 1999). A similar transitory increase of BDNF and its
Fig. 10. Preservation of the neurotrophins and their receptors in (red) from adult pig retinal glia (in vivo: A, C and E) and primary cultured cells (in vitro: B, and F). (A and B) high-
afﬁnity neurotrophin receptor, TrkA (red: C and D), low-afﬁnity neurotrophin receptor, p75 (E and F) and neurotrophin-3 (NT3) (E). In D and F, retinal ganglion cells were stained
with anti-neuroﬁlament antibodies (green). Scale bar ¼ 50 mm.
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RGCs after ischemia-reperfusion. The mechanisms underlying
BDNF induced neuroprotection are unknown, although it has been
suggested that the BDNF derived upregulation of GLAST and GS
may contribute to this effect. Indeed, BDNF has a protective effect
on GLAST and GS expression by Müller cells under hypoxic condi-
tions, which could induce neuroprotection (Dai et al., 2012b).
The Müller cell extensions that form three laminae in the IPL of
the rat retina contain p75. After ischemia, there is a progressive
disorganization of the laminae that is worse after 24hr than after2hr of reperfusion (Fig. 7). Müller cells modulate neuronal activity
by regulating the concentration of neuroactive substances and
potassium in the extracellular space by means of a variety of
transport processes (Newman and Reichenbach, 1996). Hence,
Müller cells are particularly important in ischemia when there is a
massive release of transmitters from neurons (Hossmann, 1993).
Thus, the changes seen in the p75 immunoreactivity associated
with the branches of the Müller cells in the inner plexiform layer
after ischemia may therefore indicate changes in plasticity and be
of functional signiﬁcance (Vecino et al., 1998b). Disorganization of
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in which the primary cells affected are photoreceptors, while in
glaucomatous rat retinas the cells affected are RGCs. These changes
within the Müller cells again demonstrate that Müller glia have a
radial function in the retina that senses the changes in the outer as
well as the inner retina, reacting by modulating the structure and
possibly the function of retinal neurons.
3.10.2. Other trophic factors
Ciliary neurotrophic factor (CNTF) CNTF exerts numerous ef-
fects on the development, differentiation and survival of retinal
neurons (Rhee and Yang, 2010). The molecular mechanisms that
explain the neuroprotective role of CNTF in the retina include: a
direct action on photoreceptors to prevent apoptosis; the stimula-
tion of Müller cells to produce photoreceptor survival factors (Zack,
2000); enhanced synthesis or distribution of glutamate trans-
porters, thereby improving glutamate handling and resulting in
less excitotoxic damage to retinal neurons (Escartin et al., 2006);
and an induction of metabolic plasticity and increased resistance to
metabolic damage (Escartin et al., 2007). Deﬁning the global tran-
scriptional response of Müller cells to CNTF in vivo will help
elucidate the molecular basis of its biological actions in the retina.
CNTF induces rapid and extensive transcriptional changes in Müller
cells and several genes induced by CNTF in normal Müller cells are
also up regulated in gliotic Müller cells involved in inherited and
experimentally-induced retinal degeneration. Hence, CNTF would
appear to be an inducer of gliosis in the retina. Interestingly, the
transcript proﬁles of Müller cells and astrocytes are similar
although they are derived from distinct cell lineages (Xue et al.,
2011). Exogenous CNTF initially targets Müller glia and they
trigger a reaction that induces the production of cytokines that act
through gp130 in photoreceptors to promote neuronal survival
(Rhee et al., 2013). Indeed, CNTF not only reduces the death of
photoreceptors but it also rescues retinal function (Heiduschka
et al., 2013). In addition, lens injury upregulates CNTF in retinal
astrocytes and Müller cells.
bFGF is a pleiotropic cytokine that, in addition to its pro-
angiogenic actions, may elicit further effects on retinal cells. bFGF
is found in astrocytes, Müller cells, RGCs and RPE cells. Although
bFGF is considered to be neuroprotective in the retina, it may also
have detrimental effects by stimulating aberrant vessel growth, or
inducing the proliferation and de-differentiation of Müller cells
(Bringmann et al., 2009a). Together, bFGF and VEGF act synergis-
tically onmicrovascular endothelial cells (Yan et al., 2001), whereby
the effects of bFGF are in part mediated by stimulating VEGF release
from Müller and vascular endothelial cells (Hollborn et al., 2004).
Müller cells represent a major source for bFGF in the ischemic
retina and in diabetic ﬁbrovascular tissue. The secretion of bFGF by
Müller cells is stimulated by various pro-angiogenic growth factors
and cytokines. Indeed, while the soluble factors released by Müller
cells in response to transient hypoxia produce an anti-angiogenic
environment for retinal vascular endothelial cells, persistent hyp-
oxia increases bFGF release from Müller cells, which may become
increasingly important to shift the balance between stimulators
and inhibitors of angiogenesis in the retina. In such conditions
Müller cells are likely to provide a stimulatory environment for the
proliferation of retinal vascular endothelial cells and bFGFmay play
a key role in the stimulation of abnormal vessel growth in the retina
(Yafai et al., 2013). In diabetes, the increased formation of advanced
glycation end-products (AGEs) in the vitreous humour may also be
involved in the initiation and progress of intraocular NV through
the production of bFGF by Müller cells (Ai et al., 2013).
PEDF (Pigment epithelium derived factor) Müller glial cells
are PEDF producers, a positive trophic factor expressed by activated
Müller cells. PEDF is a 50 kDa glycoprotein and it is upregulated byMüller cells following retinal hypoxia or injury. PEDF functions as
an anti-oxidative and anti-inﬂammatory agent, as well as exerting
neuroprotective and neurotrophic effects that are mediated by
activation of the NF-kB (nuclear factor kappa B) and ERK1 and 2
pathways.When secreted byMüller cells, this factor acts directly on
PEDF receptors at the surface of RGCs. The upregulation of PEDF in
Müller cells occurs early in gliosis and it may reﬂect an attempt to
rescue retinal neurons from further damage (Unterlauft et al.,
2012). Indeed, PEDF reduces RGC loss in DBA/2J mice, a mouse
model of inherited glaucoma (Zhou et al., 2009).
The expression of PEDF, Kir4.1 and GLAST by retinal Müller cells
is unbalanced at high glucose concentrations, with abnormal
expression closely related to oxidative stress. Decreased expression
of PEDF induces a down-regulation of Kir4.1 in Müller cells, causing
membrane depolarization of Müller cells and GLAST dysfunction.
Thus, retinal PEDFmust balance the anti-oxidative state against the
need to protect retinal neuronal and glial cells (Xie et al., 2012).
Further evidence for the neuroprotective actions of Müller cell
derived PEDF in the retina involves the intracellular signalling
molecules that may operate in the RGC under conditions in which
PEDF of glial origin exerts its pro-survival effects on RGCs. Thus,
PEDF-induced NF-kB activation enables RGCs to protect themselves
from hypoxia- or growth-factor deprivation-induced apoptosis.
Although not directly demonstrated, exposing RGCs to PEDF may
increase the phosphorylation of the inhibitor NF-kB, I-kB, thereby
unmasking the NF-kB/NLS domain at the C terminus of NF-kB,
stimulating its nuclear translocation and increased its DNA bind-
ing activity (Unterlauft et al., 2014).
Insulin-like growth factor-1 (IGF-1) is a polypeptide growth
factor similar in structure and function to insulin. IGF-1 has mito-
genic, metabolic and growth-stimulating activities in many cells
and tissues, including the retina, and it promotes the survival of
various cells following serum deprivation. This protective effect of
IGF-1 most probably occurs via PI3K/Akt, although the complete
details of the upstream and downstream targets have not yet been
elucidated (Guvakova, 2007).
Glial Derived Neurotrophic Factor (GDNF) in the retina has
been reported to rescue photoreceptor activity in the rd1 mouse
model of Retinitis Pigmentosa (Frasson et al., 1999) and its effects
are transmitted indirectly via activation ofMüller glia (Harada et al.,
2003; Hauck et al., 2006). Transcriptome proﬁling of the mouse
retina in response to GDNF identiﬁed osteopontin (OPN) as a novel
GDNF effector that could in part mediate in the GDNF induced
neuroprotective activity of Müller cells on photoreceptors (Del Rio
et al., 2011). OPN is secreted by Müller glia and it supports photo-
receptor survival in explant cultures of rd1 retinas, potentially
exerting a direct pro-survival effect on photoreceptors. OPN has a
signiﬁcant, concentration-dependent survival effect on primary
porcine photoreceptor cells, and it activates the PI3K/Akt pro-
survival pathway (Del Rio et al., 2011). OPN also induces the
release of VEGF, glutamate, ATP and adenosine from Müller cells.
The effect of OPN was prevented by blockers of voltage-gated so-
dium channels (tetrodotoxin), T-type voltage-gated calcium chan-
nels (kurtoxin), potassium channels (cloﬁlium) and chloride
channels (5-nitro-2-(3-phenylpropylamino)-benzoic acid) (NPPB).
The swelling-inhibitory effect of OPN was dependent on intracel-
lular calcium signalling, the activation of PLC and protein kinase C,
and vesicular exocytosis of glutamate. In retinal slices, Müller glial
cells are immunoreactive for OPN and Müller cell-derived OPN has
autocrine effects. The neuroprotective effects of OPNmay in part be
mediated by preventing the cytotoxic Müller cell swelling, and the
release of VEGF and adenosine by Müller cells (Wahl et al., 2013).
VEGF (see section on Gliosis above).
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The phagocytotic activity of Müller cells was described more
than eight decades ago. There is no evidence that these cells can
phagocytise pathogens, however the phagocytotic properties of
Müller cells were recently revaluated following Staphylococcus
aureus infection. As a result, Müller cells can apparently not only
phagocytise bacteria but they can also kill them intracellularly
(Singh et al., 2014).
Astrocytes play a role in the life cycle of axonal mitochondria at
the head of the optic nerve. Optic nerve ﬁbres discard their mito-
chondria, which are then engulfed by neighbouring astrocytes
(transmitophagy: Davis et al., 2014). In the myelination transition
zone, astrocytes have a constitutive phagocytotic role and they
express the phagocytotic marker Mac-2, which augments in glau-
coma, and it may play an important role in axonal degeneration
(Nguyen et al., 2011).
The death of RGCs after optic nerve injury involves the partici-
pation of microglia/macrophages and astroglia in a neuro-
inﬂammatory scenario. Simvastatin, a statin used to lower blood
cholesterol, may reduce NF-kB activation by TNF-a in astrocytes
maintained in culture. When administered systemically, the drug
suppresses RGC death possibly by ameliorating the astroglial re-
action to injury (Morishita et al., 2014). TNF-a can activate signal-
ling reactions involving NF-kB or C-Jun N-terminal kinase (JNK)
pathways. These pathways inﬂuence neurodegeneration and serve
as neuroprotectors. The detrimental and neuroprotective role of
TNF-a signalling was recently assessed in cultured RGCs and as-
trocytes (Dvoriantchikova and Ivanov, 2014), apparently activating
NF-kB and JNK in astrocytes but not in RGCs, indicating a contrast in
both cell populations. However, the signiﬁcance of this ﬁnding
in vivo remains unclear. TNF-a also induces the secretion of MMP-2
by optic nerve astrocytes and this secretion is attenuated by a se-
lective delta opioid agonist, SNC121 (Akhter et al., 2013).
Extracellular ATP acts as a ligand to purinergic receptors and
P2X4 purinergic receptors (ionotropic receptors) are distributed in
different cell types within the retina (bipolar cell terminals, hori-
zontal cell somata and processes, calretinin-positive amacrine
cells…etc), microglia, Müller cells and astrocytes. These receptors
inﬂuence glia function and local tissue homeostasis in both physi-
ological and pathological conditions (Vessey et al., 2014).
3.12. Repair and regeneration
Retinal astrocytes andMüller cells both producemultiple factors
that are trophic to RGCs, perhaps at different levels and under
different conditions. RGCs express a number of receptors that
respond to trophic factors including but not restricted to leukaemia
inhibitory factor (LIF), CNTF, NGF, BDNF, IGF, neurotrophins, GDNF
and FGF2 (Bonnet et al., 2004; Kinkl et al., 2003; Vecino et al.,
1998b, 2002). However, promotion of RGC survival is only tran-
sient and does not necessarily correspond with the restoration of
axonal outgrowth. In fact, whilst some of these trophic factors are
very efﬁcient at enhancing cell survival, some of them promote
axonal growth (Vecino et al., 2002), indicating that a delicate bal-
ance must exist to promote optimal RGC regeneration.
Reactive glia clearly display inhibitory properties, yet an inter-
mediate “activated” glial phenotype may also exist that favours
axonal regeneration by upregulating factors that enhance their
growth and repair, whilst keeping inhibitory responses below the
threshold for damage. Acute activation of glia is neuroprotective,
while sustained activation is detrimental, for example due to the
release of inﬂammatory cytokines. Enhanced reactivity or “activa-
tion” of retinal glia has positive effects on RGCs due to the pro-
duction of trophic factors, both in vivo after injury and also in vitro.Indeed, reactive glia secrete trophic factors distinct to those pro-
duced by quiescent glia and the degree of gliosis also appears to be
crucial to determine the success of RGC regeneration.
Can retinal glia be primed to have positive or negative effects on
RGC survival and regeneration? Müller cells secrete factors to the
media that favour the survival, regeneration and branching of RGC
axons in vitro (Garcia and Vecino, 2003; Higginson et al., 2013).
Activation of rat retinal glia (astrocytes and Müller cells), either by
lens lesion, intravitreal peripheral nerve grafting, zymosan injec-
tion or experimental glaucoma (Lorber et al., 2009, 2008, 2002,
2012), enhances the regenerative potential of RGCs in vivo and
in vitro. It is assumed that retinal glia are activated by factors pro-
duced after lens injury or peripheral nerve graft, or by macro-
phages, which may be proteinaceous or non-proteinaceous, and
that they are then stimulated to secrete neurotrophic factors that
enhance the growth of RGC axons. A trophic factor produced by
activated astrocytes and Müller cells that enhances RGC axonal
regeneration is CNTF. Its production is mediated by apolipoprotein
E (ApoE), which is upregulated in retinal astrocytes andMüller cells
after optic nerve crush and intravitreal Zymosan injections (Lorber
et al., 2009; Muller et al., 2007). Other trophic factors produced by
reactive retinal astrocytes and Müller cells that may be involved in
RGC regeneration include BDNF, GDNF and bFGF (Bonnet et al.,
2004; Garcia et al., 2002, 2003; Garcia and Vecino, 2003; Harada
et al., 2000, 2002Kinkl et al., 2003).
Although mammalian Müller glia can respond to injury, prolif-
erate and express genes that are associated with retinal stem cells
(Roesch et al., 2008), they do not function as retinal progenitors
in vivo. Nonetheless, these characteristics suggest that under the
right circumstances, Müller glia might act as retinal progenitors
that can be used for repair. The regenerative potential of Müller
cells makes them ideal candidates for cell replacement therapy to
treat retinal degenerative diseases, such as age-related macular
degeneration, retinitis pigmentosa or glaucoma, where loss of
vision correspond to retinal neuron loss. A regenerative strategy
that mobilizes the patients’ own Müller progenitors to participate
in retinal repair would have several advantages over cell trans-
plantation therapy (Ruilin et al., 2014). Indeed, in rodent and hu-
man cell cultures, Müller glia can generate both neurons and glia
(Das et al., 2006). Importantly, primary human Müller glial cell
cultures can generate photoreceptors and RGCs that have some
reparative potential when transplanted into a damaged rodent
retina. These studies suggest that human Müller glia are capable of
generating neurons under appropriate conditions and that they
may be able to participate in repair. Indeed, humanMüller glia stem
cells (hMGSCs) can differentiate into functional RGC precursors
in vitro, as conﬁrmed by their expression of RGC markers and the
increased cytosolic calcium in response to nicotinic stimulation
(Singhal et al., 2012).
Viral expression of ASCL1 is sufﬁcient to activate a neurogenic
program in mammalian Müller glial, both in dissociated cultures
and in the intact retina. ASCL1 remodels the chromatin of retinal
progenitor genes, activating their expression and downregulating
glial genes. The reprogrammed Müller glial differentiate into cells
that resemble neurons morphologically, both in terms of gene
expression and in their responses to neurotransmitters. These re-
sults suggest that stimulating neurogenesis in Müller glial with
ASCL1 could provide an alternative strategy for retinal repair after
disease or injury (Pollak et al., 2013). Similarly, manipulating the
Ephrin-A2/A3 pathway may represent a viable approach to pro-
mote the progenitor cell fate of Müller cells, since Ephrin-A2 and A3
inhibit the regenerative potential of Müller cells in the retina of
adult mice (Ruilin et al., 2014).
Among the possible molecular and cellular mechanisms con-
trolling neuronal regeneration, p53-mediated cell cycle arrest may
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adult mouse retina (Ueki et al., 2012). The loss of p53 activity could
signiﬁcantly enhance the proliferation potential of cells and facili-
tate the reprogramming of Müller glia into retinal progenitor cells
(Zhao et al., 2014a). The tumour suppressor p53 plays a funda-
mental role in astrocytes, when environmental conditions are
deleterious, as in heightened conditions of oxidative stress. In
“super p53” mice that carry two copies of the p53 gene, the density
of astrocytes is greater than in the wild type and the area they
occupy is also augmented (Salazar et al., 2013).
Atoh7 is an essential transcription factor that determines the
competence state of RGC progenitors. Ectopic expression of Atoh7
signiﬁcantly increases the number of RGCs that differentiate from
cultured retinal stem cells in vitro (Yao et al., 2007). Moreover,
Atoh7 promotes the differentiation of Müller cell-derived retinal
stem cells into RGCs by inhibiting Notch signalling, opening up a
new avenue for gene therapy and optic nerve regeneration in
glaucoma (Song et al., 2013).
Glutamate is the main neurotransmitter of the vertical signal-
ling pathway in the retina and it induces the expression of pro-
genitor cell markers in adult murine Müller glia, both in vivo and
in vitro (Takeda et al., 2008), as well as promoting the proliferation
of Müller derived progenitor cells (Ramirez and Lamas, 2009).
Glutamate can trigger de-differentiation in primary cultures of rat
Müller glial cells through a process that involves the activation of
NMDA and group II metabotropic glutamate receptors, and to some
extent the participation of global DNA demethylation via gadd45b
(Reyes-Aguirre et al., 2013).
4. Speciﬁc functions
4.1. Light guidance of Müller cells
In the mammalian retina, light has to pass the entire depth
before it arrives at the photoreceptors suggesting that speciﬁc
retinal tissue optics overcome light scattering, even in the typical
non-foveate vertebrate retina. It has been proposed that Müller
radial glial cells might act as light-guiding elements (Labin and
Ribak, 2010) and that to minimize light scattering, non-foveal
Müller cells act as living optical ﬁbres that guide light through
the inner retinal layers towards the photoreceptors, similar to glass
ﬁbre optics (Franze et al., 2007). The funnel-shaped endfoot of
Müller cells could serve as a light collector at the vitreal surface of
the retina and the stem processes as light-guiding ﬁbres. Between
the vitreous and the retina there is a ‘soft coupling’ of the light path
that reduces light reﬂection at the inner retinal surface (Franze
et al., 2007). Müller cells in the living retina minimize intraretinal
light scattering, conserving the diameter of the beam that hits a
single Müller cell endfoot. Thus, high intensity light reaches the
individual photoreceptors. Byminimizing scattering and enhancing
the signal/noise ratio, Müller cells conserve the spatial distribution
of light patterns in the propagating image. The ratio between the
numbers of cones and Müller cells is roughly 1:1, indicating an
optimal coupling between the light-guiding units and the func-
tional light pattern-sensing units (the cones: Agte et al., 2011). The
molecular basis of the light-guiding capacity of Müller cells remains
to be determined, although bundles of IFs are arranged along the
light path. In tissue edema, the neuroretina loses its transparency
and the milky opacity of the edematous tissue makes it likely that
the light guidance through Müller cells is deteriorated, resulting in
increased scattering (Reichenbach and Bringmann, 2013).
4.2. Progenitor cells
Unlike neurons, glia have the lifelong capability to de-differentiate and re-enter the mitotic cycle. Under pathological
conditions, hypertrophy and the proliferation of glial cells leads to
the formation of glial scars, which ﬁll the spaces left by dying
neurons and disconnected synapses (Reichenbach and Bringmann,
2010). Müller glia in mammalian retinas can respond to injury,
proliferate and express genes that are associated with retinal stem
cells (Roesch et al., 2008), displaying a gene expression proﬁle
resembling that of progenitor cells (Blackshaw et al., 2004). A
subset of Müller cells express progenitor genes like Car2, Dkk3,
Chx10 and Pax6 (Roesch et al., 2008; Rowan and Cepko, 2004), and
Müller cells in the adult mouse retina express cell cycle genes like
cyclinD3, Cdc14A, Cdk10 and Spbc25, as well as genes in the Notch
pathway that might regulate the re-entry of Müller glia into the cell
cycle under pathological conditions (Roesch et al., 2008).
Müller glia might adopt characteristics of retinal progenitors
that can be used to repair injured retina. In chicks (Fischer and Reh,
2001) and rats (Das et al., 2006; Ooto et al., 2004) Müller cells may
even differentiate into cone and rod photoreceptors, raising the
possibility that they may play a role as retinal stem cells. Indeed,
primary human Müller glial cell cultures can generate photore-
ceptors and RGCs that have some reparative potential when
transplanted into a damaged rodent retina (Jayaram et al., 2014).
Thus, Müller glia might be the ideal candidate for cell replacement
therapy to treat retinal degenerative diseases where vision loss is
caused by retinal neuron loss (Ruilin et al., 2014).
Müller glia with stem cell characteristics have been identiﬁed in
the adult human eye and although there is no evidence that they
regenerate the retina in vivo, they can be isolated and grown in
culture and can be induced to express retinal neuron markers
in vitro (Lawrence et al., 2007). Both hMGSCs and RGC precursors
differentiate, as shown by the expression of RGC markers and the
increase in cytosolic Ca2þ in response to nicotinic stimulation
(Singhal et al., 2012), the former generating functional newly born
RGCs in response to BMP, FGF2 and the secretase inhibitor (DAPT).
This provides important evidence that hMGSCs can be differenti-
ated in vitro into functional RGCs, providing a potential application
in cell-based therapies to treat conditions in which RGCs are
compromised (Becker et al., 2013). In addition, an immortalized
human Müller glial cell line (MIO-M1) has been established that
can maintain its characteristics over 50 sub-culture passages (Limb
et al., 2002).
Cell-derived micro vesicles (MVs: recognized as important
components of cellecell communication) contain mRNAs, miRNAs,
proteins and lipids, and they can transfer their bioactive contents
from parent cells to cells of other origins. Embryonic stem cell
microvesicles (ESMVs) induce de-differentiation and the pluripo-
tency of Müller cells after prolonged exposure, opening an avenue
to employ ESMVs in therapies to induce and support the retina's
endogenous regenerative capacity (Katsman et al., 2012).
The viral expression of ASCL1 is sufﬁcient to activate a neuro-
genic programme in mammalian Müller glia, both in dissociated
cultures and in the intact retina. The reprogrammed Müller glia
differentiate into cells that morphologically resemble neurons, in
both their gene expression and their responses to neurotransmit-
ters. Hence, stimulating neurogenesis in Müller glia with ASCL1
could provide an alternative strategy for retinal repair after disease
or injury (Pollak et al., 2013). Manipulating the ephrin-A2/A3
pathway may also represent an alternative means to promote the
progenitor cell fate of Müller cells (see above: Ruilin et al., 2014).
Among the possible molecular and cellular mechanisms that
control neuronal regeneration, p53-mediated cell cycle arrest may
play an important inhibitory role in Müller glia behaviour in the
adult mouse retina (Ueki et al., 2012). Loss of p53 activity can
signiﬁcantly enhance the proliferation potential of cells and facili-
tate the reprogramming of Müller glia into retinal progenitor cells
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inﬂuence astrocytes (see above). The possible inﬂuence of Atoh7
and glutamate in promoting the generation and proliferation of
Müller glia derived progenitor cells has also been addressed above.
Little is known about the role of BMPs in Müller glial prolifer-
ation although a novel role for BMP in the control of Müller glial
proliferation was recently described. Treating the mouse retina
with EGF stimulates the BMP signalling pathway in Müller glia,
causing them to release BMP7. This autocrine BMP release activates
the BMP receptors on Müller glia, promoting Smad1/5/8 phos-
phorylation and an increase in Id1. Hence, BMP can inﬂuence the
mitogenic pathway regulating Müller glial proliferation, which has
implications for both vitreoretinopathy and regenerative ap-
proaches to address retinal disease (Ueki and Reh, 2013).
The capacity of some astrocytes to enter a re-programmed state
of pluripotency and subsequently, to serve as progenitors capable of
generating neurons suggests a reparative function that merits
attention (Buffo et al., 2008; Wang et al., 2008; Wohl et al., 2012) In
fact, the generation of neurons from astrocytes has been reported
in vitro and it depends on speciﬁc transduction mechanisms
mediated by key transcription factors like Pax 6 (Heins et al., 2002)
or Mash 1 (Ding et al., 2014).
5. Heterogeneity of retinal glial cells
5.1. Astrocyte heterogeneity
The phenotypic heterogeneity among glial cell types is an
emerging area of research in glial biology. Whilst most of the
attention to date has focused on astrocyte subpopulations in the
brain white matter (Chaboub and Deneen, 2012), there is some
evidence to support the existence of glial subpopulations within
the adult mammalian retina. At least nine types of astrocytes with
different morphological characteristics have been described in the
normal brain. Moreover, morphologically undistinguishable astro-
cytes can exhibit different physiological behaviour (Matyash and
Kettenmann, 2010). The existence of different astrocyte pop-
ulations is reinforced by the ﬁnding that astrocyte reactivity takes
place in selected areas of the glaucomatous retina, these “micro-
domains” possibly serving as biomarkers and predictors of RGC
health (Formichella et al., 2014).
Astrocytes form a family of diverse populations adapted to their
speciﬁc localization. Astrocytes in different brain regions have
distinct physiological properties, and they express various sets of
receptors and transporters, probably in response to their local
environment. Within the retina the situation is similar and when
primary retinal astrocytes are cultured, different types are evident
that vary in their expression of neurotransmitters and molecularFig. 11. Astrocyte heterogeneity. (A) Pig retinal astrocytes labelled with antibodies against
vessels of a pig eye ball that was preserved in vitro for 12 h in oxygenated medium. Note tha
and located in parallel to the RGC axons.markers, and in their shape. For example, AQP4 is present in large
amounts in the astrocyte plasma membranes when they are in
contact with microvessels. AQP4 inﬂuences many process (the
volume of the extracellular space, waste clearance, potassium
buffering, cell migration and calcium signalling: Nagelhus and
Ottersen, 2013) and signiﬁcantly, its expression is altered in dia-
betic retinopathy (Qin et al., 2012). Astrocytes may play a role in the
transport of exosomes with different cargos between neurons
(Edelstein and Smythies, 2014; Kawikova and Askenase, 2014). In a
laser-induced choroidal neovascularisation (CNV) model, retinal
astrocytes release exosomes containing anti-angiogenic com-
pounds that protect the eye from the deleterious effects of neo-
vascularisation (Hajrasouliha et al., 2013).
Differential expression of TrkA, the NGF receptor, led us to
identify two sub-populations of astrocytes in the adult human and
pig retina. While most astrocytes in the nerve ﬁbre layer (NFL)
express TrkA, a small population in the INL do not express this
receptor (Ruiz-Ederra et al., 2003). A separate study of adult human
retinal astrocytes identiﬁed 3 different sub-populations character-
ized by the expression of GFAP and Vimentin; GFAPþ/Vimentinþ,
GFAPþ/Vimentin and GFAP/Vimentinþ (Perez-Alvarez et al.,
2008). The physiological signiﬁcance of this, if any, is not yet
known but these data provide further strong evidence for the
heterogeneity of retinal astrocytes.
In addition to the two sub-populations of astrocytes showing
distinct TrkA expression in the INL, we found another possible sub-
population of retinal astrocytes based on their function. Thus, only
a subpopulation of astrocytes were able to take up Fluorogold
injected systemically in the blood vessels of the optic nerve of pig
eyes when incubated over night in oxygenated cultured medium.
Given their morphology, we propose that these specialized cells are
the functional “perivascular astrocytes” described previously in the
human eye (Wolter, 1956). These astrocytes are preferentially
connected to blood vessels while the rest of the astrocytes in the
NFL of the retina connect mainly with RGC axons (Fig. 11).
Interspecies differences have been observed in the distribution
of astrocytes, which is very similar in the pig and humanwhere two
types of astrocytes are found: stellate astrocytes that form cell
clusters; and elongated astrocytes located in the NFL (Ruzafa et al.,
2014). By contrast, only stellate astrocytes are found in rodents.
Interspecies differences in brain astrocytes have also been found
and differences exist between rodent and human astrocytes in
similar areas of the cortex, including differences in size, branching
area and calcium waves (Oberheim et al., 2009).
5.2. Müller cell heterogeneity
Little is known about the heterogeneity of Müller cells, althoughGFAP. (B) Astrocytes labelled with ﬂuoro-gold FG injected into the optic nerve blood
t in A there is at least one other type of astrocyte not associated with the blood vessels
Fig. 12. Müller cell heterogeneity in vitro. Conﬂuent pig Müller cells monolayer
cultured for 10 days and labelled with (A) antibodies against-GFAP (green) and (B)
glutamine synthetase (GS, red). C) Co-localisation of both antibodies plus nuclei
stained with DAPI (blue). Note that even when there are many Müller cells in a ﬁeld,
there are only two cells with strong GS-immunoﬂuorescence: one with strong GFAP
ﬂuorescence and another with an intermediate strength of GS ﬂuorescence but
negative for GFAP (top right). Scale bar ¼ 50 mm.
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suggesting that these might be involved in retinal immune re-
actions (Roberge et al., 1985). In an attempt to deﬁne the tran-
scriptome of Müller glia, certain genes were seen to be expressed
heterogeneously among the Müller glial cells including common
housekeeping genes like b-actin, b-2-microglobulin, heat shock
protein 1 b and TATA box binding protein (Roesch et al., 2008). It is
clear that molecular differences exist in Müller cells because the
homeodomain containing transcription factor Chx10 is expressed
only in a subset of Müller glia (Rowan and Cepko, 2004). Hetero-
geneous gene expression among Müller glial cells was observed
over a large cluster, yet further characterization of the glial genes
identiﬁed will be required to clarify the diversity among Müller
glial cells and to shed light on their potential functional diversity
(Roesch et al., 2008). A comparison of the Müller glia transcriptome
with that of other glial cell types in the CNS failed to reveal common
clusters of gene expression (Bachoo et al., 2004). This might be due
to technical differences or it might reﬂect a distinct genetic
constitution. However, the expression of some transcripts was
common to Müller glia and other glial cell types, and some tran-
scripts enriched in Müller glia are also enriched in astrocytes
include peroxiredoxin 6, Basigin (also called CD147), caveolin, CD9
antigen, carboxypeptidase (Roesch et al., 2008).
Isolated cells in vitro can respond to certain conditions by
rapidly changing their protein expression and transforming to a
proliferative phenotype. While vimentin remains stably expressed
in these cells, GFAP expression, which is probably induced during
their isolation from the intact retina, is rapidly lost in vitro (Fischer
et al., 2004). This is consistent with reports from the chick retina
where only the sub-population of GFAP negative retinal Müller glia
become proliferative following NMDA-induced retinal damage,
possibly indicating that the primary retinal Müller glia represent
only a glial subpopulation (Hauck et al., 2014).
Other evidence for phenotypic diversity among Müller glia in-
cludes the variation in nestin expression in Müller cells after retinal
detachment from adult rats (Luna et al., 2010). A different post-
injury response may be elicited in individual Müller cell pop-
ulations and since nestin is a marker of immature Müller cells,
perhaps sub-populations exist with enhanced regenerative prop-
erties. Furthermore, a gene expression analysis of Müller cells in a
mouse model of retinitis pigmentosa revealed signiﬁcant inherent
heterogeneity amongst individual wild type cells, with further di-
versity amongst individual cells post-injury (Roesch et al., 2012).
Heterogeneity in GS or GFAP expression was observed in pri-
mary Müller cell cultures from adult rat or pig, and cells expressing
high amounts of GS or GFAP lie close to others that do not express
these markers (Fig. 12). This was evident in both pure glial cell
cultures as well as in Müller-RGC co-cultures. In addition, RGCs
prefer to grow on Müller cells that overexpress GS, their regener-
ating axons following a very precise path over the surface of Müller
cells that contain GS and avoiding the surrounding cells without GS
(Fig. 13). This heterogeneity among Müller cells would perhaps also
reﬂect different glialeneuronal interactions that may have neuro-
protective effects on retinal neurons.
Reactive Müller cells upregulate GS, possibly as a neuro-
protective mechanism to limit glutamate neurotoxicity (Gorovits
et al., 1997). Whilst this is not a direct interaction between glia
and RGCs, it does represent an important effect of glia on RGC
survival and retinal homeostasis.
6. Glia and retinal pathologies
Microglia perform valuable activities in the retina under phys-
iological conditions by interacting with other cell populations in
the retinal layers. Maintenance of homeostasis is a complex task inwhich all cells in a tissue participate. Likewise, when things go
wrong due to trauma or disease, the community of retinal cells
responds and collaborates to restore a healthy state. However, this
cannot always be achieved and the damage may seriously and
irreversibly affect retinal function. Indeed, many pathological
conditions may alter the integrity of the retina. In the case of
neurodegenerative diseases the role of microglia is variable, and
both their pathogenic engagement and neuroprotective role are
entangled (i.e.: capacities and limits). Thus, both these roles must
be fully understood to adequately design external interventions
aimed at preventing, alleviating or eliminating the damage (Prinz
et al., 2011).
Retinal damage results from the action of different etiological
agents, such as elevated intraocular pressure, altered vascularisa-
tion, ageing, genetic defects. In different retinal neurodegenerative
diseases the cell signals and changes, like the inﬂammatory re-
sponses, exhibit both similar and singular characteristics, and
therefore, therapeutic interventions must be based on knowledge
of the common and distinct patterns of the disease (Cuenca et al.,
2014). The effect of a glial response contralateral to the damaged
eye has been demonstrated and it is very possible that inﬂamma-
tion caused by the way to increase intraocular pressure with laser
could be the cause of such contralateral reactions (Gallego et al.,
2012; Ramirez et al., 2010; Rojas et al., 2014). It is thus very
important to pay attention to the inﬂammation caused in the
different experimental models of eye damage since in addition to
elevation of intraocular pressure, it is possible that other retina
damage can be caused to the retina.
Fig. 13. Preference of RGCs grown in vitro on Müller cells that express GS strongly. (A)
Rat RGCs were cultured on conﬂuent pig retinal Müller cells monolayer where the
nuclei are labelled with DAPI (blue), the glutamine synthetase is labelled in Müller
cells (GS, green) and the RGCs are stained with antibodies against-ßIII Tubulin (red).
(B) RGCs have a preference for those Müller cells that express GS strongly. Scale
bar ¼ 50 mm.
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Diabetic retinopathy (DR) is a long term complication of type 1
and type 2 diabetes. In both the proliferative (angiogenesis
observed) and non-proliferative (disrupted blood vessels detected)
forms of DR, activation of a plethora of signalling pathways ulti-
mately results in retinal damage and visual loss (Grigsby et al.,
2014). Dysregulated metabolites (including glucose, amino acids,
lipids, amines, vitamins, minerals, etc) disturb the homeostasis of
growth factors, neurotrophic factors, cytokines and adhesion mol-
ecules, consequently affecting capillary permeability and cell
turnover. Therefore, many related and unrelated biochemical
pathways are involved in the complex pathophysiology of DR (Ola
et al., 2012), which explains why a precise picture of the mecha-
nisms related to the onset and progression of the disease is not yet
clear. Moreover, individual genetic susceptibility and habits inﬂu-
ence the development and morbidity of the disease, which may
eventually lead to partial or total loss of vision as a consequence of
retinal destruction and/or detachment (Grigsby et al., 2014).
Clearly, DR has an important inﬂammatory component, where
microglia participate as both prey and enforcer, together with otherretinal cell populations, including neurons, glial cells and reduced
myeloid populations (for a review see (Grigsby et al., 2014).
As a consequence of consistent high blood glucose levels in DR,
AGE appear (molecules that are non-enzymatically glycated in the
presence of aldoses), dyslipemia occurs and there is an increase in
ROS that activates retinal microglia. As a result, the microvascula-
ture, as well as other glia and neurons suffer damage (Fletcher et al.,
2005; Grigsby et al., 2014; Wong et al., 2011). Various experimental
animal models of DR have provided useful information about the
molecular events involved in the disease. Alloxan or STZ (strepto-
zotozin) are toxic agents that speciﬁcally destroy pancreatic islet
beta cells and induce diabetes (Larger et al., 1995; Mansford and
Opie, 1968), while Goto Kakizaki (GK) rats are a non-obese model
for spontaneous type 2 diabetes developed by select breeding
(Kitahara et al., 1978). The retina of these experimental animals can
be used to analyse the role of microglia, in vivo and in vitro: their
migratory, secretory and growth activities, as well as their neuro-
protective capacity. Also, human subjects can be used to study the
disease, although with evident limitations.
Microglial activation in DR has been observed at early stages of
this progressive disease and an increase in microglial density oc-
curs in the GCL and NFL, with a decrease in the IPL. The alignment of
microglial processes along the optic nerve is also disrupted (Chen
et al., 2014). It is noteworthy that the precise mechanism(s) of
glial activation in DR and other retinopathies are not fully under-
stood. A few examples illustrate the speciﬁc and partial relevance of
several actors. The accumulation of AGA (Amadori-glycated albu-
min), an AGE product in early DR induces TNF-a secretion by
microglia (Ibrahim et al., 2011). Moreover, in an experimental rat
model of diabetes, activated microglia more intensely express TNF-
a and IL-1b mRNA, and interestingly, minocycline (a tetracycline
antibiotic with anti-inﬂammatory activity) produces an approxi-
mate 50% decrease in the transcripts encoding these two cytokines
(Krady et al., 2005). Another agent analyzed in DR is aldose
reductase (an enzyme that catalyzes the synthesis of polyols),
which is activated in DR (Kinoshita, 1986). Aldose reductase par-
ticipates in the activation of retinal microglia and its inhibition or
its genetic deﬁciency signiﬁcantly reduces the inﬂammatory
changes caused by microglia activation (Chang et al., 2014),
ameliorating the degeneration of capillaries and the generation of
superoxide anions found in DR (Tang et al., 2013). The participation
of signalling pathways related to the microglial adenosine receptor
A2A has also been documented (see Santiago et al., 2014).
In cases of disease or trauma, astrocytes react and become
activated (Pekny et al., 2014; Yang et al., 2014), undergoing a series
of changes (proliferation/migration, hypertrophy, GFAP expression,
secretion of pro-inﬂammatory signals that include IL-6, MCP-1 and
MIP-2alp) aimed at tackling the insult in cooperation with other
glial cells (Nahirnyj et al., 2013). As a consequence of astrocyte
activation, RGCs receive both positive and negative signals, and the
disturbance of the homeostatic scenario triggers the death of
resident retinal cells. Astrocytes also respond to aggression and in
diabetes for example, high glucose levels alter astrocyte inﬂam-
matory cytokine expression, activating NF-kB and increasing
oxidative stress (Shin et al., 2014). In glaucoma and other degen-
erative retinal diseases, oxidative stress and death by apoptosis are
known features, as are astrocytic TNF-a/TNFR signalling, nuclear
factor (NF-kB) activation, and p53 and caspase 3 upregulation
(Rogers et al., 2012; Tezel et al., 2012). In neurodegeneration glial
activity also deteriorates.
Elevation of histone acetylation in Müller cells plays an impor-
tant regulatory role in the inﬂammatory response during diabetes
(Wang et al., 2012). It has also been proposed that in early phases of
diabetic retinopathy, Müller glial activation does not contribute to
neurodegeneration but that it may provoke neuroprotection
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involving phosphorylation of extracellular signal-regulated kinase
1/2, pERK1/2: (Matteucci et al., 2014). Since in vitro high glucose
stimulation of Müller cells increases VEGF secretion, the speciﬁc
ERK1/2 inhibitor, U0126, blocked ERK1/2 phosphorylation and
thus, impaired the Müller cells secretion of VEGF that is implicated
in the development of diabetic retinopathy (Ye et al., 2010). Thus,
targeting ERK1/2 signalling in Müller cells, through the upstream
signalling pathway or nuclear transcription factors of VEGF secre-
tion, could represent a promising future treatment for diabetic
retinopathy.
6.2. Glaucoma
Glaucoma encompasses several diseases that destroy RGCs and
their axons in the optic nerve through apoptosis (Garcia-Valenzuela
et al., 1995), provoking progressive loss of the visual ﬁeld and
blindness (Mi et al., 2014; Quigley, 2011; Rieck, 2013). The aetiology
and pathophysiology of glaucoma is not well known, although
several risk factors andmechanisms that inﬂuence the disease have
been found. Among these factors, the elevation of intraocular
pressure (IOP) is particularly important, while other factors have
also all been associated with the disease, like: low diastolic ocular
perfusion pressure (calculated as 2/3 mean arterial pressure-IOP),
other ocular hemodynamic parameters, systemic diseases such as
sustained high blood pressure or diabetes, ethnic group, age,
myopia, migraine, the nutritional state of RGCs (Hernandez et al.,
2009).
Human glaucoma can be classiﬁed into three main categories:
primary open angle glaucoma (POAG), primary closed-angle glau-
coma (PCAG) and primary congenital glaucoma (PCG: Ahonen et al.,
2014; Quigley, 2011). Each of these has speciﬁc and common
characteristics, related to alterations of the aqueous humour
outﬂow and abnormalities in the anterior chamber angle (Ahonen
et al., 2014; Liu et al., 2013). The structural changes in the outﬂow
system involve a thickening of the trabecular beam, cell death in
the cribriform layer, accumulation of extracellular material and
plaque formation (Fuchshofer et al., 2006; Rohen et al., 1981).
However, a clear relationship between elevated IOP, structural al-
terations to the Schlemm's canal cells that respond to local me-
chanical changes, and the preponderant intervention of the
mechanisms related to the onset and progression of the disease are
not yet fully known (Galdos and Vecino, 2011; Overby et al., 2014;
Vecino et al., 2015a) Interestingly, therapies that lower IOP slow the
progress of different types of glaucoma, yet other treatments aimed
at avoiding cell death are required.
Due to the limitations faced when studying human individuals,
animal models of induced or spontaneous glaucoma are efﬁcient
tools to discover and deﬁne the aetiological factors, pathological
mechanisms, and the extent and consequences of RGC death.
Moreover, reliable animal models are needed to assess the thera-
peutic value of drugs in preclinical trials (Smedowski et al., 2014).
However, since differences in retinal anatomy and physiology be-
tween animal species exist, and the procedures used to obtain such
experimental models may vary, it is necessary to ascertain the
advantages and limitations of a particular model, and carefully
choose the pertinent one in function of the damage caused to the
optic nerve and the reproducibility (Smedowski et al., 2014; Vecino,
2008).
Neuroinﬂammation is a common aspect of many neurodegen-
erative diseases, including glaucoma, and microglia participate in
their pathology, although the precise extent to which they inﬂu-
ence each disease is not yet clear. Microglial activation has been
observed both in eyes affected by ocular hypertension and in the
healthy contralateral eyes (Rojas et al., 2014), indicating complexmechanisms are at play that involve both structural and diffusible
elements. Microglial fractalkine may be a key element of the
neurotoxicity exerted by microglia in an experimental model of
induced glaucoma since suppression of its CX3CR1 receptor
induced more extensive RGC death when IOP was elevated (Wang
et al., 2014). A relationship between the release of cytokines (IL-6,
IL-1, TNF-a, etc) and the initiation of apoptosis has been established
(Gonzalez-Scarano and Baltuch, 1999). The intervention of neuro-
toxic agents, alone or in collaboration, has been studied in vivo and
in vitro, in different animal models or in humans. Thus, while there
is abundant information, the immune system is complex, making it
difﬁcult to deﬁne the main causes and the accompanying phe-
nomena. RGC death in glaucoma probably depends on the
concurrence of several stressors (for instance ROS, glutamate,
mitochondrial impairment…), as well as ill-tuned or adapted
cellular responses (Rieck, 2013). Thus, full resolution of this “puz-
zle” will require more effort.
Gene expression dependent on TGF-b2 activation in astrocytes
cultured from the optic nerve head is reduced after antioxidant
treatment, indicating that antioxidants may have a place in the
treatment of neurodegenerative diseases like glaucoma (Yu and
Welge-Lussen, 2013). Astrocytes undergo morphological changes
related to the damage produced in RGCs (Lye-Barthel et al., 2013).
Hypertrophia of astrocytes was observed in the optic nerve in a rat
in vivo model of transient intraocular hypertension, as was early
up-regulation of phosphorylated STAT3 (signal transducer and
activator of transcription protein 3), a key transcription factor that
regulates the expression of many genes and that may play a crucial
role in the activation of astrocytes after an increase in IOP (Zhang
et al., 2013). Indeed, it is proposed that the damage observed in
optic nerve axons after an increase in IOP is secondary to the
damage induced in astrocytes, which suggests they are the primary
site of damage in early stages of glaucoma (Dai et al., 2012a).
In a mouse model of hereditary glaucoma (DBA/2J), an increase
in BDNF in hypertrophic astrocytes was concomitant with a deﬁcit
in anterograde axonal transport prior to RGC synapse loss (Crish
et al., 2013). Hence, astrocytes may respond to the diminished
axonal transport by taking up BDNF from target neurons to mini-
mize the damage. It is very possible that the same mechanism will
work at the onset of glaucoma and that after the ﬁrst days of high
IOP, the homeostatic mechanisms in the retina will be altered and
glial cells will then orchestrate the events that will provoke the
death of certain RGCs. It is unclear why not all RGCs die at the same
time in Glaucoma, however, the glial environment of the vulnerable
RGCs may be different and thus, these RGCs might respond to the
malevolent signals in a more aggressive manner.
In rats where glaucoma was induced by cauterization of epis-
cleral veins, in addition to RGC death changes in amacrine and bi-
polar cells were found, as well as astrocyte activation in the
damaged but not the contralateral eye (Hernandez et al., 2010). The
function of astrocyte and Müller cell activation is unknown as yet,
although one week after the IOP elevation we observe more
astrocyte gliosis that decreased thereafter (Hernandez et al., 2010).
It is possible that the astrocytes detect the increase in pressure
directly, or through microglial or Müller cells, and they react by
liberating neurotrophic signals that could help RGCs to resist the
insult. It is also possible that glial cells may provide mechanical
support. Another possible function of reactive astrocytes might be
related to repairing the damage to the blood retina barrier (Bush
et al., 1999; Voskuhl et al., 2009). However, the detrimental side
of astrogliosis is that reactive astrocytes may potentially exacerbate
the glaucomatous process by overexpressing toxins, producing a
direct toxic effect on RGCs. Müller cells overexpress GS, especially
in their inner and outer regions, while the vimentin cytoskeleton is
also partially disorganized (Fig. 14). AQP9 expression is reduced in
Fig. 14. Glial cells in glaucomatous retinas. Comparative distribution of glial cells between control (A, C, E) and glaucomatous (B, D, F) rat retinas. A and B are whole-mount retinas
where the astrocytes were labelled with antibodies against-GFAP (green). Note the change in astrocyte morphology in the glaucoma retina (in B) compared to the control (A).
Vimentin (C, D) and glutamine synthetase (E, F) immunoreactivity (red) is evident in Müller cells. Nuclei were DAPI labelled (blue). Note the change in vimentin expression that is
more disorganized (D) than in the control eye (C) and GS expression is increased in F with respect to the control eye in E. Scale bar ¼ 50 mm.
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expression in the Müller cell endfeet. Alternatively, the expression
of both AQP7 and AQP9 is reduced in the ciliary body of glaucom-
atous eyes. Therefore, AQP expression seems to play some role in
glaucoma (Tran et al., 2014).
Under normal conditions, resident macrophages maintain tis-
sue homeostasis by removing dead cells and other debris, and by
producing growth factors. However, under noxious conditions the
cellular stress response is activated that results in cell-
autonomous adaption. However, communication between
stressed cells and other cells in a tissue may also occur, including
resident macrophages. If the nature or the extent of stress is such
that it affects not only individual cells but also the entire tissue
(e.g. hypoxia or hyperthermia), then a tissue-level stress response
or parainﬂammation is elicited by the resident macrophages.
Depending on the strength of the noxious conditions, this
response can involve the recruitment of different types of circu-
lating inﬂammatory monocytes. Parainﬂammation may alsoinvolve the mild release of plasma components into the affected
tissue and if the condition is sufﬁciently severe (e.g., infection or
injury), an acute inﬂammatory response ensues. This is charac-
terized by the recruitment of neutrophils and specialized subsets
of monocytes from the circulation that help to protect the host
from infection, promoting tissue repair and restoration of ho-
meostasis (Medzhitov, 2008, 2010). This could be the case of
experimental damage to the eyewhere strong inﬂammation could
activate resident cells and the immune system. Since astrocytes
and microglial cells have receptors for inﬂammation, this could
explain the contralateral response to damage in experimental
models of hypertension when laser damage causes intense
inﬂammation of the eye. It could also be relevant to situations in
humans where inﬂammation of different sources (uveitis, trauma,
etc…) could activate the immune system and affect the contra-
lateral eye. We must pay close attention to the different experi-
mental models to induce hypertension and glaucoma (Ruiz-
Ederra et al., 2005; Vecino and Sharma, 2011).
E. Vecino et al. / Progress in Retinal and Eye Research 51 (2016) 1e40306.3. Age-related macular degeneration (AMD)
Advanced age is a risk factor for numerous pathologies, collab-
orating with other intrinsic and extrinsic cues that provoke the
initiation of a given disease. The brain and the retina suffer age-
related deterioration/degeneration (Harry, 2013), and to discover
the importance of age in this process, which cannot be avoided or
changed, it is paramount to unravel the inﬂuence of the other main
aetiological elements (for example life-style and environmental
factors) on the initiation and progression of neurodegeneration.
Microglia populate the retina early in the embryonic period and
their persistence during adulthood depends on self-renewal
through multiple divisions (Ginhoux et al., 2010). Microglial sen-
esce has been observed in healthy aging rats in conjunction with
telomere shortening and reduced telomerase activity (Flanary et al.,
2007). Other observations indicate that old microglia suffer age-
related alterations in their dynamic capacities (motility, branch-
ing, length of processes, etc.) and that they are less responsive to
external stimuli like ATP (Damani et al., 2011). Hence, the homeo-
static role of microglia can be seriously altered with age (Karlstetter
and Langmann, 2014).
AMD is a neurodegenerative disorder in which age plays a
principal role. The most common form of this disease is the atro-
phic or “dry” form that is characterized by RPE degeneration and
central retina photoreceptor death. In the exudative or “wet” form,
choroidal neo-vascularization is observed (Ma et al., 2009; Zhao
et al., 2014b). In healthy retinas, microglia are located in the inner
retina and they are scarce or non-existent in the outer retina and
retino-choroidal zone. However, in AMD the distribution of
microglia changes dramatically. Activatedmicroglia migrate to sub-
retinal locations and in some cases, they come into close contact
with drusen deposits (Ma et al., 2009, 2012). In an in vitro model
where microglial cells were co-cultivated with primary RPE cells
and in an in vivo mouse model where microglia were transplanted
into the sub-retinal space, microglia appear to be responsible for
early alterations to RPE cells, and the initiation of a pro-
inﬂammatory and pro-angiogenic environment (Ma et al., 2009).
Therefore, the translocation of microglia to the outer retina may be
an essential event that triggers chronic inﬂammation related to the
progress of AMD.
Genetic models provide valuable information to analyse the
pathology of age-related neurodegeneration and to study the
participation of microglia in such processes (Karlstetter et al., 2010).
For example, knock-out mice develop some characteristics of AMD
at old ages, such as Ccl2 (CCL2 is a chemokine) and Cx3cr1 deﬁcient
animals, and the Ccl2/Cx3cr1 double knock-out developed evident
lesions consistent with AMD earlier: RPE atrophy, photoreceptor
death, neovascularisation, and migration of microglia to the outer
nuclear layer and sub-retinal spaces (Tuo et al., 2007). In a knock-
out mice deﬁcient in Nrf2 (nuclear erythroid 2-related factor e a
transcription factor that regulates the expression of protective
proteins against oxidative stress), the abnormal presence of
microglia, regulatory T cells and IL-17 (interleukin 17) producing T
cells in the retina and at sub-retinal locations has been documented
(Zhao et al., 2014b). Therefore, the destruction of the RPE in early
AMD favours the inﬁltration of circulating blood cells that
contribute signiﬁcantly to the pathology and progression of AMD.
The AhR (a nuclear aryl hydrocarbon receptor) signalling pathway
is a defence mechanism that detoxiﬁes metabolic waste molecules
and xenobiotics, and its activity in human RPE cells diminishes with
age (Hu et al., 2013). A knock-out mouse model deﬁcient in AhR
(Ahr/) exhibits phenotypic characteristics of AMD, indicating that
this signalling pathway may hinder the appearance of AMD (Hu
et al., 2013; Kim et al., 2014). Accordingly, a complex collabora-
tion of mechanisms dependent on immune competent cells andRPE cells appears to be responsible for the initiation and progres-
sion of AMD.
6.4. Retinitis pigmentosa (RP)
RP is a group of heterogeneous inherited diseases in which the
primary defect affects the retina, alone or in association to other
anomalies affecting different organs. RP is characterized by
photoreceptor degeneration and progressive blindness, yet the
molecular and cellular mechanisms involved in photoreceptor
death are not completely understood. Only when the mechanisms
underlying this damage are known can effective treatments follow.
As in other retinal pathologies, inﬂammation plays a fundamental
role in RP and it has been associated with mutations that affect
more than 70 genes related to different retinal functions (photo-
transduction, cell cycle proteins, ciliary proteins, structural pro-
teins, transcription factors, see RetNet at https://sph.uth.edu/
retnet/disease.htm). However, in some cases the genetic defect is
yet to be deﬁned. Recently, a dominant mutation in the gene that
encodes HK1 (hexokinase 1, an enzyme that catalyzes the phos-
phorylation of glucose in the glucolytic pathway) was found to
cause RP (Sullivan et al., 2014).
Microglia sense the environment and they rapidly respond to
disturbances by trying to protect neurons against insults (neuro-
protection). However, the persistence of damage may activate the
neurotoxic phenotype of microglia, in an attempt to limit the
damage (Langmann, 2007). The early intervention of microglia in
degeneration suggests that they play an active role in pathological
mechanisms. In vitro and in vivo studies have characterized
microglial behaviour in RP and other degenerative retinal diseases
by studying their temporal transcription proﬁles, secretomes,
phenotypic changes and migration (Karlstetter et al., 2010;
Langmann, 2007). Using genetic mouse models and in vitro ap-
proaches, the complex and multiple effects of microglia as key el-
ements in RP and other examples of inherited retinal degeneration
can be illustrated. An analysis of microglia transcripts and
morphology in a retinoschisin-deﬁcient mouse that suffers a severe
photoreceptor dystrophy indicated thatmicroglia act in early stages
of the diseases (Gehrig et al., 2007; Karlstetter et al., 2010). In a
mouse RPmodel, rd (carrying a spontaneous defect in the b subunit
of rod cGMP-phosphodiesterase), early activation of microglia was
again seen by analysing the expression of microglial chemokine
transcripts and the secretion of TNF-a, which appeared prior to or
concomitant with photoreceptor death (Zeng et al., 2005).
Microglia-mediated neurotoxicity in photoreceptors is also sup-
ported by the activation of microglial NADPH oxidase, which gen-
erates ROS (Zeng et al., 2014). When the rd10 mouse model of RP is
crossed with a Cx3cr1GFP/GFP mouse, microglial activation was
evident as an early phenomenon in RP and Cx3cl1/Cx3cr1 signalling
signiﬁcantly amelioratedmicroglia neurotoxicity (Peng et al., 2014).
Moreover, administration of minocycline for several days inhibited
microglia activation, reducing photoreceptor death and improved
vision in rd10 mice (Peng et al., 2014). Chemical destruction of
microglia in rd10 mouse retinal explants with clodronate-
containing liposomes slowed photoreceptor death, yet the neuro-
protective effect of IGF-I was attenuated when microglia were
depleted. These ﬁndings suggest a misbalance in the microglial
neuroprotective/neurotoxic intervention in this retinal dystrophy
(Arroba et al., 2011, 2014). In a ratmodel of RP bearing amutation in
the rhodopsin-encoding gene (P23H), microglial cells were more
abundant in all retinal layers and they were also present in the sub-
retinal space. Treatment of these rats with taurodeoxycholic acid
prevented microglial activation and delayed photoreceptor death
(Noailles et al., 2014).
Not only are microglial cells activated in RP but Müller cells are
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a natural model of RP in dogs, the RP65 mutant. Müller cells also
respond to the ongoing disease process, although this responsewas
not uniform against all the proteins examined. The low-afﬁnity p75Fig. 15. Retinitis pigmentosa (RP). Comparison of the glia in controls (A, D, G, J) and adult
associated virus (AAV) vector containing a functional copy of the RPE65 gene (AAV-RPE6
Müller cells are stained with antibodies against p75 (red). The BDNF expression in RGCs de
increased in affected dogs and RPE65 expression (green) is lost in affected animals but it is
appears disorganized in the affected and in the treated dogs. Increased expression of CRALBP
treated dogs (I). (JeL) Vimentin is expressed in Müller cells (red, DeF), and it was enhance
bar ¼ 50 mm.receptor was expressed in Müller cells and it increased in the
mutant retina, with expression in radial Müller ﬁbres and sur-
rounding RGCs. Both vimentin and GFAP expression also increased,
although more prominently in younger animals than in adults. Bydog models of RP, RPE65/ (B, E, H, K) and adult dog RPE65/ treated with adeno-
5: C, F, I, L). (AeC) RGCs are labelled with antibodies against-BDNF (green) and the
creased in affected retinas and increased after treatment. (DeF) GFAP expression (red)
recovered in treated dogs. (GeI) CRALBP was expressed in Müller cells (green) and it
was found in RPE in affected dogs (H) and it returned to control levels in gene-therapy
d in the affected (K) and treated (L) dogs. Nuclei were stained with DAPI (blue). Scale
E. Vecino et al. / Progress in Retinal and Eye Research 51 (2016) 1e4032contrast, CRALBP did not show an initial increase and it was
expressed below control levels in adult mutant dogs. It is clear that
Müller cells respond to outer retinal disease. The response was
mild, transient and more intense in the younger than in the older
mutant retinas, possibly indicating a lack of progressive retinal
degenerative changes in the period analyzed. However, only a
limited number of antibodies were analysed, two of which were
directed at IFs. It is possible that other proteins (e.g., GC and car-
bonic anhydrase C) would respond differently as they are known to
decrease in experimental retinal detachment in adult cats (Lewis
et al., 1994).
Therapeutic approaches in RP and other hereditary diseases
involving retinal degeneration might aim to restore the gene defect
by gene-replacement (Beltran et al., 2014) or stem-cell trans-
plantation (He et al., 2014). Retinal degeneration might also be
palliated or slowed by controlling the neuroinﬂammatory frame-
work. This can be achieved with either immune-suppressant or
immunomodulatory drugs (Karlstetter et al., 2010). Another strat-
egy includes the administration of protective molecules, such as
rod-derived cone viability factors, to preserve cone-dependent
central vision after rod death (Leveillard et al., 2014). In addition,
the application of sub-retinal photovoltaic arrays that restore
photoreceptor function can be applied when the inner retinal cir-
cuits are preserved (Light et al., 2014). Indeed different therapeutic
approaches should target the speciﬁc features of each type of RP
and hereditary retinal degeneration.
In diseases where the outer part of the retina is affected,
Müller cells sense the damage in the outer retina and transmit the
information to the inner retina. This event can be studied in dogs
carrying a mutation similar to Leber Congenital Amaurosis (LCA),
a speciﬁc type of RP. This disease comprises a group of childhood-
onset, autosomal recessive retinal diseases that result in severe
visual impairment or blindness (den Hollander et al., 2008). LCA
is caused by mutations in the RPE65 gene, which encodes the
65 kDa RPE-speciﬁc isomerase involved in visual pigment
regeneration (Gu et al., 1997). The RPE65 protein is essential to
maintain retinal function and photoreceptor viability, and for
retinoid cycling between the RPE and photoreceptors (Saari,
2000). Mutations in RPE65 occur naturally in dogs (Aguirre
et al., 1998), and gene therapy studies in these dogs (Acland
et al., 2001) has led to the ﬁrst gene therapy undertaken in
humans (Hauswirth et al., 2008). We studied the molecular
changes that take place in the retina of the mutant dogs as they
mature (Hernandez et al., 2010) and found activation of astrocytes
in the GC layer, even when the damage to the retina originated in
the RPE. Hence, Müller cells appear to sense the changes in the
outer part of the retina and communicate these to cells located in
the inner part of the retina. Moreover, astrocytes located in the
neighbourhood of RGCs may also sense that synaptic trans-
mission was disturbed and react to this malfunction. Interest-
ingly, after gene therapy with an adeno-associated virus to
restore the mutated RP65 gene (AAV_RPE65), and even when
functional recovery was achieved (Acland et al., 2001), the glial
cells remained activated 6e24 months after treatment (Fig. 15).
Only the CRALBP immunoreactivity in the RPE returned to normal
levels after gene therapy, while Müller cells remained activated,
as evident by examining vimentin labelling. Müller cells can
change the morphology of their membranes, adapting to the
changes in the damaged cells surrounding them. After this
damage and retinal function is restored, as is this case with this
gene therapy, Müller cells should return to the original state in a
plastic-like process, although has yet to be conﬁrmed (after the
submission of this review and during the process of revision a
book on retinal glia appeared where details of each cell type are
addressed: Reichenbach and Bringmann, 2015).7. Conclusions, remarks and future directions
The retina contains three major classes of glia, Müller cells, as-
trocytes and a resident subpopulation of microglial cells. All are
integratedwith the neurons that form the retina and allow a correct
functioning of the retina. Müller cells, astrocytes and microglia are
all capable of phagocytosis, responding to immunological damage
and they interact with neurons, thereby modulating the synapses.
Moreover, the three cell types play a role in the metabolism of
neurons, which is affected by their distribution and physiological
state. Since the neurons in the retina are highly specialized, their
metabolic demands are also very speciﬁc, and glial cells sur-
rounding these neurons provide different nutrients. Therefore, it is
crucial that when exploring the changes within the retina, an in-
tegrated approach should be adopted that considers glialeneuron
interactions, in order to fully understand the retina in health and
disease.
The source and age of glia is an important factor when deter-
mining the support that astrocytes or Müller glia can offer to RGCs.
Much of the research concerning themolecular mechanisms of RGC
processing in association with retinal glia has been carried out
using embryonic tissue, the rational being that axon outgrowth
during development could provide insight into the deﬁcits under-
lying unsuccessful adult regeneration. Whilst much information
can be gleaned from these studies, there are limitations to the
comparisons that can be made, since there is a wealth of evidence
showing that adult RGCs and glia have a highly altered molecular
repertoire when compared to their embryonic and postnatal
counterparts. Therefore, it is imperative that attention is paid to
study adult RGCs and adult retinal glia.
The other limitation to studies in early periods is the use of
astrocytes from non-retinal sources. We are now only just begin-
ning to understand the complexity of glial heterogeneity and the
roles of different subpopulations within a single tissue, and further
research on the adult retina is required to explore the possibility
that some populations of retinal glia are more supportive of RGCs
than others. The molecular changes that take place in the adult
retina after damage occur rapidly, within minutes or hours. How-
ever, the return to a normal situation can take years, although some
restoration of function can be achieved in a shorter period.
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